<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="hfi" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">hfi</book-part-id>
      <title-group>
        <title>Hereditary Fructose Intolerance</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Baker</surname>
            <given-names>Peter</given-names>
            <suffix>II</suffix>
          </name>
          <degrees>MD, FAAP, FACMG</degrees>
          <aff>Children&#x02019;s Hospital Colorado<break/>University of Colorado School of Medicine<break/>Aurora, Colorado</aff>
          <email>peter.baker@childrenscolorado.org</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Ayres</surname>
            <given-names>Lachlan</given-names>
          </name>
          <degrees>MB, ChB, MRCP</degrees>
          <aff>Royal United Hospitals Bath<break/>NHS Foundation Trust<break/>Bath, United Kingdom</aff>
          <email>lachlan.ayres@nhs.net</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Gaughan</surname>
            <given-names>Sommer</given-names>
          </name>
          <degrees>RD, CSP</degrees>
          <aff>Children&#x02019;s Hospital Colorado<break/>Aurora, Colorado</aff>
          <email>sommer.gaughan@childrenscolorado.org</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Weisfeld-Adams</surname>
            <given-names>James</given-names>
          </name>
          <degrees>MB, ChB, FAAP, FACMG</degrees>
          <aff>Children&#x02019;s Hospital Colorado<break/>University of Colorado School of Medicine<break/>Aurora, Colorado</aff>
          <email>james.weisfeld-adams@childrenscolorado.org</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date iso-8601-date="2015-12-17" date-type="created">
          <day>17</day>
          <month>12</month>
          <year>2015</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="folate-mal" document-type="chapter">Hereditary Folate Malabsorption</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="deafness-overview" document-type="chapter">Hereditary Hearing Loss and Deafness Overview</related-object>
      <abstract id="hfi.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>Following dietary exposure to fructose, sucrose, or sorbitol, untreated hereditary fructose intolerance (HFI) is characterized by metabolic disturbances (hypoglycemia, lactic acidemia, hypophosphatemia, hyperuricemia, hypermagnesemia, hyperalaninemia) and clinical findings (nausea, vomiting, and abdominal distress; chronic growth restriction/failure to thrive). Untreated HFI typically first manifests when fructose- and sucrose-containing foods are introduced in the course of weaning young infants from breast milk. If large quantities of fructose are ingested, the infant may acutely develop lethargy, seizures, and/or progressive coma. Untreated HFI may result in renal and hepatic failure. If identified and treated before permanent organ injury occurs, individuals with HFI can experience a normal quality of life and life expectancy.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The diagnosis of HFI is established in a proband (with suggestive metabolic disturbances and clinical findings following dietary exposure to fructose, sucrose, or sorbitol) who has demonstrated either biallelic pathogenic variants in <italic toggle="yes">ALDOB</italic> on molecular genetic testing or deficient hepatic fructose 1-phosphate aldolase (aldolase B) activity on liver biopsy.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> Acute manifestations (e.g., lethargy, seizures, or progressive coma and/or renal and hepatic failure) should be managed symptomatically in a hospital setting, including intravenous glucose (dextrose) administration, supportive treatment of hepatic insufficiency, and treatment of metabolic acidosis, if present.</p>
          <p><italic toggle="yes">Prevention of primary manifestations:</italic> Dietary restriction of fructose, sucrose, and sorbitol is the cornerstone of HFI treatment. Specific agents to be avoided include fructose, high-fructose corn syrup, honey, agave syrup, inverted sugar, maple-flavored syrup, molasses, palm or coconut sugar, and sorghum. In addition, medicines and formulas in which fructose/sucrose may not be listed as a primary component need to be avoided; examples include syrups, enema solutions, some immunoglobulin solutions, and many infant and pediatric nutritional drinks. During hospitalizations special caution is advised to avoid use of fructose-containing intravenous fluids.</p>
          <p><italic toggle="yes">Prevention of secondary complications:</italic> Given that reduced fruit and vegetable intake is a dietary requirement, daily supplementation with a &#x0201c;sugar-free&#x0201d; multivitamin is recommended to prevent micronutrient deficiencies, specifically water-soluble vitamins.</p>
          <p><italic toggle="yes">Surveillance:</italic> No formal guidelines for surveillance exist. Once the diagnosis of HFI has been made, periodic evaluation of liver function, renal function, and growth is reasonable, particularly if compliance with the fructose/sucrose/sorbitol-restricted diet is not absolute.</p>
          <p>
            <italic toggle="yes">Agents/circumstances to avoid:</italic>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Enteral or parenteral exposure to fructose, sorbitol, sucrose, sucralose, and polysorbate.</p>
            </list-item>
            <list-item>
              <p>Fructose tolerance testing (&#x02018;fructose challenge&#x02019;) in the diagnosis of HFI.</p>
            </list-item>
          </list>
          <p><italic toggle="yes">Evaluation of relatives at risk:</italic> Presymptomatic diagnosis and treatment is warranted for sibs at risk in order to avoid life-threatening complications by restriction of fructose intake as soon as possible.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>HFI is inherited in an autosomal recessive manner. At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being a carrier, and a 25% chance of being unaffected and not a carrier. Carrier testing for at-risk relatives and prenatal testing for pregnancies at increased risk are possible if both <italic toggle="yes">ALDOB</italic> pathogenic variants have been identified in an affected family member.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="hfi.Diagnosis">
        <title>Diagnosis</title>
        <p>There are no formal diagnostic guidelines for hereditary fructose intolerance (HFI).</p>
        <sec id="hfi.Suggestive_Findings">
          <title>Suggestive Findings</title>
          <p>Hereditary fructose intolerance (HFI) <bold>should be suspected</bold> in individuals with the following characteristic metabolic disturbances and clinical findings following dietary exposure to fructose, sucrose, or sorbitol:</p>
          <p>
            <bold>Characteristic metabolic disturbances</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Hypoglycemia (plasma glucose &#x0003c;60 mg/dL; reference range 70-120 mg/dL)</p>
            </list-item>
            <list-item>
              <p>Lactic acidemia (plasma lactate &#x0003e;2.5 mmol/L; reference range: 0.5-2.2 mmol/L)</p>
            </list-item>
            <list-item>
              <p>Hypophosphatemia</p>
            </list-item>
            <list-item>
              <p>Hyperuricemia (plasma uric acid &#x0003e;5.0 mg/dL; reference range 2.0-5.0 mmol/L)</p>
            </list-item>
            <list-item>
              <p>Hypermagnesemia</p>
            </list-item>
            <list-item>
              <p>Hyperalaninemia</p>
            </list-item>
          </list>
          <p>
            <bold>Characteristic clinical findings</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Nausea, vomiting, and abdominal distress</p>
            </list-item>
            <list-item>
              <p>Chronic growth restriction/failure to thrive</p>
            </list-item>
          </list>
        </sec>
        <sec id="hfi.Establishing_the_Diagnosis">
          <title>Establishing the Diagnosis</title>
          <p>The diagnosis of HFI <bold>is established</bold> in a proband with suggestive metabolic disturbances and clinical findings following dietary exposure to fructose, sucrose, or sorbitol who has demonstrated EITHER of the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>Biallelic pathogenic variants in <italic toggle="yes">ALDOB</italic> on molecular genetic testing (<xref ref-type="table" rid="hfi.T.summary_of_molecular_genetic_testi">Table 1</xref>)</p>
            </list-item>
            <list-item>
              <p>Deficient hepatic fructose 1-phosphate aldolase (aldolase B) activity on liver biopsy</p>
            </list-item>
          </list>
          <p>Note: Because of the relatively high sensitivity of <italic toggle="yes">ALDOB</italic> molecular genetic testing it is increasingly the preferred confirmatory test for HFI and can obviate the need for liver biopsy.</p>
          <p><bold>Molecular testing approaches</bold> can include <bold>single-gene testing</bold>, use of a <bold>multi-gene panel</bold>, and <bold>more comprehensive genomic testing</bold>.</p>
          <p>
            <bold>Single-gene-testing</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Sequence analysis</bold> is performed first, followed by gene-targeted deletion/duplication analysis if only one or no pathogenic variant is identified.</p>
            </list-item>
            <list-item>
              <p><bold>Targeted analysis for the following pathogenic variants</bold> can be performed first &#x02013; if appropriate &#x02013; in individuals with specific ancestry:</p>
              <list list-type="bullet">
                <list-item>
                  <p>European: p.Ala150Pro and p.Ala175Asp</p>
                </list-item>
                <list-item>
                  <p>Northern India: c.324+1G&#x0003e;A</p>
                </list-item>
              </list>
            </list-item>
          </list>
          <p><bold>A multi-gene panel</bold> that includes <italic toggle="yes">ALDOB</italic> and other genes of interest (see <xref ref-type="sec" rid="hfi.Differential_Diagnosis">Differential Diagnosis</xref>) may also be considered. Note: The genes included in the panel and the diagnostic sensitivity of the testing used for each gene vary by laboratory and over time.</p>
          <p><bold>More comprehensive genomic testing</bold> (when available) including whole-exome sequencing (WES), whole mitochondrial sequencing (WMitoSeq), and whole-genome sequencing (WGS) may be considered if serial single-gene testing (and/or use of a multi-gene panel that includes <italic toggle="yes">ALDOB</italic>) fails to confirm a diagnosis in an individual with features of hereditary fructose intolerance. Such testing may provide or suggest a diagnosis not previously considered (e.g., mutation of a different gene that results in a similar clinical presentation). For more information on comprehensive genome sequencing click <related-object link-type="booklink" source-id="gene" document-id="app5" document-type="appendix" object-id="app5.Comprehensive_Genome_Sequencing" object-type="sec">here</related-object>.</p>
          <table-wrap id="hfi.T.summary_of_molecular_genetic_testi" position="anchor" orientation="portrait">
            <label>Table 1. </label>
            <caption>
              <p>Summary of Molecular Genetic Testing Used in Hereditary Fructose Intolerance</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_hfi.T.summary_of_molecular_genetic_testi_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                  <th id="hd_h_hfi.T.summary_of_molecular_genetic_testi_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Test Method</th>
                  <th id="hd_h_hfi.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Proportion of Probands with Pathogenic Variants&#x000a0;<sup>2</sup> Detectable by This Method</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_hfi.T.summary_of_molecular_genetic_testi_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                    <italic toggle="yes">ALDOB</italic>
                  </td>
                  <td headers="hd_h_hfi.T.summary_of_molecular_genetic_testi_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>3</sup><hr/></td>
                  <td headers="hd_h_hfi.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">66%-100%&#x000a0;<sup>4</sup><hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_hfi.T.summary_of_molecular_genetic_testi_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Gene-targeted deletion/duplication analysis&#x000a0;<sup>5</sup></td>
                  <td headers="hd_h_hfi.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">0%-20%&#x000a0;<sup>6,&#x000a0;7,&#x000a0;8</sup></td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="hfi.TF.1.1">
                <label>1. </label>
                <p>See <related-object source-id="gene" document-id="hfi" object-id="hfi.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
              </fn>
              <fn id="hfi.TF.1.2">
                <label>2. </label>
                <p>See <xref ref-type="sec" rid="hfi.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants detected in this gene.</p>
              </fn>
              <fn id="hfi.TF.1.3">
                <label>3. </label>
                <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
              </fn>
              <fn id="hfi.TF.1.4">
                <label>4. </label>
                <p>The most commonly identified pathogenic variants in European and North American populations are p.Ala150Pro and p.Ala175Asp. The c.324+1G&#x0003e;A splice variant is common in a population from Northern India [<xref ref-type="bibr" rid="hfi.REF.dursun.2001.523">Dursun et al 2001</xref>, <xref ref-type="bibr" rid="hfi.REF.s_nchezguti_rrez.2002.e56">S&#x000e1;nchez-Guti&#x000e9;rrez et al 2002</xref>, <xref ref-type="bibr" rid="hfi.REF.santer.2005.594">Santer et al 2005</xref>, <xref ref-type="bibr" rid="hfi.REF.gruchota.2006.376">Gruchota et al 2006</xref>, <xref ref-type="bibr" rid="hfi.REF.davitspraul.2008.443">Davit-Spraul et al 2008</xref>, <xref ref-type="bibr" rid="hfi.REF.coffee.2010.33">Coffee et al 2010</xref>, <xref ref-type="bibr" rid="hfi.REF.ferri.2012.31">Ferri et al 2012</xref>, <xref ref-type="bibr" rid="hfi.REF.bijarniamahay.2015.85">Bijarnia-Mahay et al 2015</xref>].</p>
              </fn>
              <fn id="hfi.TF.1.5">
                <label>5. </label>
                <p>Gene-targeted deletion/duplication analysis detects intragenic deletions or duplications. Methods that may be used include: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a gene-targeted microarray designed to detect single-exon deletions or duplications.</p>
              </fn>
              <fn id="hfi.TF.1.6">
                <label>6. </label>
                <p><xref ref-type="bibr" rid="hfi.REF.cross.1990.101">Cross &#x00026; Cox [1990]</xref>, <xref ref-type="bibr" rid="hfi.REF.santer.2005.594">Santer et al [2005]</xref>, <xref ref-type="bibr" rid="hfi.REF.davitspraul.2008.443">Davit-Spraul et al [2008]</xref>, <xref ref-type="bibr" rid="hfi.REF.esposito.2010.1294">Esposito et al [2010]</xref></p>
              </fn>
              <fn id="hfi.TF.1.7">
                <label>7. </label>
                <p>No large deletions were identified by Southern blotting in 56 individuals from Spain [<xref ref-type="bibr" rid="hfi.REF.s_nchezguti_rrez.2002.e56">S&#x000e1;nchez-Guti&#x000e9;rrez et al 2002</xref>].</p>
              </fn>
              <fn id="hfi.TF.1.8">
                <label>8. </label>
                <p>A large (6.5-kb) intragenic deletion with an allele frequency of 11% was identified in a small Italian cohort [<xref ref-type="bibr" rid="hfi.REF.ferri.2012.31">Ferri et al 2012</xref>].</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p><bold>Deficient hepatic fructose 1-phosphate aldolase (aldolase B) activity</bold>
<bold>on liver biopsy.</bold> Specific fructose-1-phosphate aldolase B enzyme assays and fructose assay enzyme panels on frozen liver tissue may be important options for the diagnosis in individuals with clinical and biochemical features of HFI in whom sequence analysis has failed to identify biallelic <italic toggle="yes">ALDOB</italic> pathogenic variants.</p>
        </sec>
      </sec>
      <sec id="hfi.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="hfi.Clinical_Description">
          <title>Clinical Description</title>
          <p>Hereditary fructose intolerance (HFI) typically manifests when fructose and sucrose-containing foods are introduced in the course of weaning young infants from breast milk [<xref ref-type="bibr" rid="hfi.REF.ali.1998.353">Ali et al 1998</xref>]. Manifestations include nausea, bloating, vomiting, sweating, abdominal pain, and growth retardation [<xref ref-type="bibr" rid="hfi.REF.odi_vre.1978.605">Odi&#x000e8;vre et al 1978</xref>].</p>
          <p>Impaired gluconeogenesis following fructose ingestion may result in acute hypoglycemia which is refractory to glucagon [<xref ref-type="bibr" rid="hfi.REF.van_den_berghe.1973.637">Van Den Berghe et al 1973</xref>]. For example, infants who ingest large quantities of fructose may develop lethargy, seizures, and/or progressive coma, or neonates given a 24% sucrose solution for analgesia during minor procedures may develop hypoglycemia.</p>
          <p>Other biochemical features of HFI include hypermagnesemia, hyperuricemia, hypophosphatemia, and metabolic acidosis [<xref ref-type="bibr" rid="hfi.REF.bouteldja.2010.105">Bouteldja &#x00026; Timson 2010</xref>].</p>
          <p>Other less common findings in HFI include:</p>
          <list list-type="bullet">
            <list-item>
              <p>Lenticular cataracts, intermittent liver enzyme abnormalities, or chronic liver disease of early or late onset [<xref ref-type="bibr" rid="hfi.REF.locher.1987.194">Locher 1987</xref>, <xref ref-type="bibr" rid="hfi.REF.krawczy_ski.1994.702">Krawczy&#x00144;ski et al 1994</xref>, <xref ref-type="bibr" rid="hfi.REF.w_ssmann.2000.108">W&#x000f6;ssmann et al 2000</xref>, <xref ref-type="bibr" rid="hfi.REF.ananth.2003.87">Ananth et al 2003</xref>];</p>
            </list-item>
            <list-item>
              <p>Coagulopathy [<xref ref-type="bibr" rid="hfi.REF.hoskov_.1977.63">Hoskov&#x000e1; &#x00026; Mrskos 1977</xref>];</p>
            </list-item>
            <list-item>
              <p>Isolated poor growth [<xref ref-type="bibr" rid="hfi.REF.mock.1983.764">Mock et al 1983</xref>];</p>
            </list-item>
            <list-item>
              <p>Intermittent vomiting in the setting of fructose aversion and pristine dentition [<xref ref-type="bibr" rid="hfi.REF.newbrun.1980.619">Newbrun et al 1980</xref>].</p>
            </list-item>
          </list>
          <p>Typically, when complete dietary fructose, sucrose, and sorbitol restriction is implemented early in life and adherence is maintained (see Management, <xref ref-type="sec" rid="hfi.Prevention_of_Primary_Manifestations">Prevention of Primary Manifestations</xref>), the prognosis for individuals with HFI is excellent (i.e., normal neurocognitive development, health, and life expectancy).</p>
          <p>Conversely, when individuals with HFI do not adhere to recommended dietary restrictions, chronic liver and/or renal disease are expected; however, long-term natural history studies in untreated individuals are lacking [<xref ref-type="bibr" rid="hfi.REF.odi_vre.1978.605">Odi&#x000e8;vre et al 1978</xref>]. Of note, historical reports describe adults with HFI who survived following self-imposed low fructose diets which they refined through trial and error.</p>
          <p>Of note, dental researchers have conflicting observations about oral health in individuals with HFI: one group observed a lower incidence of dental caries and periodontal disease as a result of self-imposed dietary restrictions of sugar [<xref ref-type="bibr" rid="hfi.REF.marthaler.1967.597">Marthaler &#x00026; Froesch 1967</xref>], whereas another group speculated that fructose restriction may itself contribute to periodontal disease as oral microbiome changes appeared to increase the risk for gingival bleeding and calculi in treated individuals [<xref ref-type="bibr" rid="hfi.REF.sax_n.1989.150">Sax&#x000e9;n et al 1989</xref>].</p>
          <p><bold>Heterozygotes (carriers)</bold> are not at increased risk of developing HFI. While carriers are generally asymptomatic, in older reports hyperuricemia was observed in some presumed or obligate carriers and, thus, these individuals may be predisposed to gout/crystal arthropathy [<xref ref-type="bibr" rid="hfi.REF.oberhaensli.1987.931">Oberhaensli et al 1987</xref>, <xref ref-type="bibr" rid="hfi.REF.seegmiller.1990.8326">Seegmiller et al 1990</xref>].</p>
        </sec>
        <sec id="hfi.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>No genotype-phenotype correlations have been identified for HFI; clinical severity and extent of organ damage appear to depend on an individual&#x02019;s nutritional environment.</p>
        </sec>
        <sec id="hfi.Nomenclature">
          <title>Nomenclature</title>
          <p><xref ref-type="bibr" rid="hfi.REF.chambers.1956.340">Chambers &#x00026; Pratt [1956]</xref> reported &#x0201c;idiosyncrasy to fructose&#x0201d; in a female age 24 years who developed gastrointestinal symptoms and syncopal symptoms following fructose or sugar ingestion.</p>
          <p>&#x0201c;Fructosaemia,&#x0201d; a term originally proposed by <xref ref-type="bibr" rid="hfi.REF.levin.1963.220">Levin et al [1963]</xref> to describe the presence of abnormal quantities of fructose in plasma, is now considered obsolete. This finding, which is not specific to HFI, is also observed in fructokinase deficiency and other disorders [<xref ref-type="bibr" rid="hfi.REF.hommes.1993.788s">Hommes 1993</xref>].</p>
        </sec>
        <sec id="hfi.Prevalence">
          <title>Prevalence</title>
          <p>Hereditary fructose intolerance (HFI) is rare, making precise prevalence estimates challenging.</p>
          <p>European estimates for the prevalence (based on results of carrier testing for common <italic toggle="yes">ALDOB</italic> pathogenic variants and use of the Hardy-Weinberg principle after correction for the estimated detection rate) are between 1:18,000 and 1:31,000 (<xref ref-type="table" rid="hfi.T.hfi_prevalence_by_population_based">Table 2</xref>).</p>
          <p>It is important to note that the US study which targeted five specific <italic toggle="yes">ALDOB</italic> alleles [<xref ref-type="bibr" rid="hfi.REF.lazarin.2013.178">Lazarin et al 2013</xref>] may underestimate the prevalence in persons of non-European ancestry. Applying a Bayesian framework to population-based genomic data, <xref ref-type="bibr" rid="hfi.REF.schrodi.2015.659">Schrodi et al [2015]</xref> devised posterior probability density prevalence estimates for HFI; based on available data, prevalence of HFI was estimated as 1:34,461 (95% credible interval 1:16,800 to 1:94,500).</p>
          <table-wrap id="hfi.T.hfi_prevalence_by_population_based" position="anchor" orientation="portrait">
            <label>Table 2. </label>
            <caption>
              <p>HFI Prevalence by Population Based on Carrier Testing for Specific <italic toggle="yes">ALDOB</italic> Pathogenic Variants</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_1_1" rowspan="2" valign="middle" colspan="2" align="left" scope="colgroup" headers="hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_1_1"/>
                  <th id="hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_1_2" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_1_2">UK&#x000a0;<sup>1</sup></th>
                  <th id="hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_1_3" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_1_3">Germany&#x000a0;<sup>2</sup></th>
                  <th id="hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_1_4" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_1_4">Poland&#x000a0;<sup>3</sup></th>
                  <th id="hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_1_5" valign="middle" colspan="3" align="left" scope="colgroup" rowspan="1">US<hr/></th>
                </tr>
                <tr>
                  <th headers="hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_1_5" id="hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_2_1" valign="middle" colspan="1" align="left" scope="colgroup" rowspan="1">All&#x000a0;<sup>4</sup></th>
                  <th headers="hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_1_5" id="hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_2_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">ME&#x000a0;<sup>4</sup></th>
                  <th headers="hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_1_5" id="hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_2_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">AA&#x000a0;<sup>4</sup></th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_1_1" valign="middle" colspan="2" align="left" scope="row" rowspan="1">
                    <bold>Extrapolated HFI prevalence&#x000a0;<sup>5</sup></bold>
                    <hr/>
                  </td>
                  <td headers="hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">1:18,000<hr/></td>
                  <td headers="hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">1:26,000<hr/></td>
                  <td headers="hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">1:31,000<hr/></td>
                  <td headers="hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_1_5 hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">1:60,000<hr/></td>
                  <td headers="hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_1_5 hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">1:38,000<hr/></td>
                  <td headers="hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_1_5 hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">1:205,000<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_1_1" rowspan="4" valign="middle" align="left" scope="row" colspan="1">
                    <bold>Variants tested</bold>
                  </td>
                  <td headers="hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_1_1" valign="middle" align="left" rowspan="1" colspan="1">p.Ala150Pro<hr/></td>
                  <td headers="hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">X<hr/></td>
                  <td headers="hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">X<hr/></td>
                  <td headers="hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">X<hr/></td>
                  <td headers="hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_1_5 hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_2_1 hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_2_2 hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_2_3" valign="middle" colspan="3" align="left" rowspan="1">X<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_1_1" valign="middle" colspan="1" align="left" scope="row" rowspan="1">p.Ala175Asp<hr/></td>
                  <td headers="hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                    <hr/>
                  </td>
                  <td headers="hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">X<hr/></td>
                  <td headers="hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">
                    <hr/>
                  </td>
                  <td headers="hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_1_5 hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_2_1 hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_2_2 hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_2_3" valign="middle" colspan="3" align="left" rowspan="1">X<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_1_1" valign="middle" colspan="1" align="left" scope="row" rowspan="1">p.Asn335Lys<hr/></td>
                  <td headers="hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                    <hr/>
                  </td>
                  <td headers="hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">X<hr/></td>
                  <td headers="hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">
                    <hr/>
                  </td>
                  <td headers="hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_1_5 hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_2_1 hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_2_2 hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_2_3" valign="middle" colspan="3" align="left" rowspan="1">X<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_1_1" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Other</td>
                  <td headers="hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_1_5 hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_2_1 hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_2_2 hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_2_3" valign="middle" colspan="3" align="left" rowspan="1">p.Tyr205Ter, p.Asn120LysfsTer32</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn>
                <p>ME = Middle Eastern</p>
              </fn>
              <fn>
                <p>AA = African American</p>
              </fn>
              <fn id="hfi.TF.2.1">
                <label>1. </label>
                <p>Based on the UK population prevalence of the p.Ala150Pro allele, the final estimate for the incidence of HFI was 1:18,000 live births [<xref ref-type="bibr" rid="hfi.REF.james.1996.837">James et al 1996</xref>]</p>
              </fn>
              <fn id="hfi.TF.2.2">
                <label>2. </label>
                <p>
                  <xref ref-type="bibr" rid="hfi.REF.santer.2005.594">Santer et al [2005]</xref>
                </p>
              </fn>
              <fn id="hfi.TF.2.3">
                <label>3. </label>
                <p>
                  <xref ref-type="bibr" rid="hfi.REF.gruchota.2006.376">Gruchota et al [2006]</xref>
                </p>
              </fn>
              <fn id="hfi.TF.2.4">
                <label>4. </label>
                <p>In a large carrier screening study of multiple disorders in an ethnically diverse population in the United States, overall carrier frequency for an <italic toggle="yes">ALDOB</italic> pathogenic variant was 1:122 (~0.8%). Carrier frequencies in persons self-identifying as Middle Eastern (n=388) and African American (n=678) were 1:97 (~1.0%) and 1:226 (~0.4%), respectively. Using the Hardy-Weinberg principle, these data yield disease frequency estimates of 1:60,000 for all the US population, 1:38,000 for US population identified as Middle Eastern, and 1:205,000 for US population identified as African American [<xref ref-type="bibr" rid="hfi.REF.lazarin.2013.178">Lazarin et al 2013</xref>].</p>
              </fn>
              <fn id="hfi.TF.2.5">
                <label>5. </label>
                <p>Extrapolated prevalence based on detection rate of variants tested</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
      </sec>
      <sec id="hfi.Genetically_Related_Allelic_Disorder">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>No phenotypes other than those discussed in this <italic toggle="yes">GeneReview</italic> are known to be associated with pathogenic variants in <italic toggle="yes">ALDOB</italic>.</p>
      </sec>
      <sec id="hfi.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>In addition to hereditary fructose intolerance (HFI), the following disorders should be considered in the evaluation of hepatic insufficiency, unexplained jaundice [<xref ref-type="bibr" rid="hfi.REF.leonardi.1986.189">Leonardi et al 1986</xref>], and hypoglycemia, or in the setting of Reye-like illness in infancy or early childhood [<xref ref-type="bibr" rid="hfi.REF.yang.2000.218">Yang et al 2000</xref>, <xref ref-type="bibr" rid="hfi.REF.thabet.2002.581">Thabet et al 2002</xref>]:</p>
        <list list-type="bullet">
          <list-item>
            <p>Infectious hepatitis, sepsis, or disseminated intravascular coagulation [<xref ref-type="bibr" rid="hfi.REF.maggiore.1982.169">Maggiore &#x00026; Borgna-Pignatti 1982</xref>]</p>
          </list-item>
          <list-item>
            <p>Autoimmune liver disease</p>
          </list-item>
          <list-item>
            <p>Neonatal hemochromatosis which is considered a congenital alloimmune hepatitis</p>
          </list-item>
          <list-item>
            <p>Toxic ingestion</p>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="hlh" document-type="chapter">Hemophagocytic lymphohistiocytosis</related-object> [<xref ref-type="bibr" rid="hfi.REF.mandel.1990.267">Mandel et al 1990</xref>]</p>
          </list-item>
          <list-item>
            <p>
              <related-object link-type="booklink" source-id="gene" document-id="alpha1-a" document-type="chapter">Alpha-1 antitrypsin deficiency</related-object>
            </p>
          </list-item>
          <list-item>
            <p>
              <related-object link-type="booklink" source-id="gene" document-id="tyrosinemia" document-type="chapter">Tyrosinemia type 1</related-object>
            </p>
          </list-item>
          <list-item>
            <p>
              <related-object link-type="booklink" source-id="gene" document-id="galactosemia" document-type="chapter">Galactosemia</related-object>
            </p>
          </list-item>
          <list-item>
            <p>
              <related-object link-type="booklink" source-id="gene" document-id="ucd-overview" document-type="chapter">Urea cycle disorders</related-object>
            </p>
          </list-item>
          <list-item>
            <p>
              <related-object link-type="booklink" source-id="gene" document-id="citrin" document-type="chapter">Citrin deficiency</related-object>
            </p>
          </list-item>
          <list-item>
            <p>Fatty acid oxidation disorders (including <related-object link-type="booklink" source-id="gene" document-id="mcad" document-type="chapter">MCAD deficiency</related-object>, LCHAD deficiency [<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/609016">OMIM</ext-link>], and <related-object link-type="booklink" source-id="gene" document-id="vlcad" document-type="chapter">VLCAD deficiency</related-object>)</p>
          </list-item>
          <list-item>
            <p>Organic acidemias</p>
          </list-item>
          <list-item>
            <p>
              <related-object link-type="booklink" source-id="gene" document-id="msud" document-type="chapter">Maple syrup urine disease</related-object>
            </p>
          </list-item>
          <list-item>
            <p>
              <related-object link-type="booklink" source-id="gene" document-id="wilson" document-type="chapter">Wilson disease</related-object>
            </p>
          </list-item>
          <list-item>
            <p>Hepatic glycogenosis: <related-object link-type="booklink" source-id="gene" document-id="gsd1" document-type="chapter">glycogen storage disease (GSD) types Ia and Ib</related-object>, <related-object link-type="booklink" source-id="gene" document-id="gsd3" document-type="chapter">GSD III</related-object>, <related-object link-type="booklink" source-id="gene" document-id="gsd4" document-type="chapter">GSD IV</related-object>, <related-object link-type="booklink" source-id="gene" document-id="gsd6" document-type="chapter">GSD VI</related-object>, GSD types IXa1 and IXa2 (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/306000">OMIM</ext-link>), GSD IXb (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/261750">OMIM</ext-link>), GSD IXc (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/613027">OMIM</ext-link>), and GSD XI (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/612933">OMIM</ext-link>)</p>
          </list-item>
          <list-item>
            <p>Disorders of mitochondrial DNA depletion (including <related-object link-type="booklink" source-id="gene" document-id="dguok-mtddepl" document-type="chapter"><italic toggle="yes">DGUOK</italic></related-object><italic toggle="yes">-</italic>, <related-object link-type="booklink" source-id="gene" document-id="mpv17-mtdep" document-type="chapter"><italic toggle="yes">MPV17</italic></related-object><italic toggle="yes">-</italic>, and <related-object link-type="booklink" source-id="gene" document-id="alpers" document-type="chapter"><italic toggle="yes">POLG</italic></related-object>-related disorders)</p>
          </list-item>
          <list-item>
            <p>Transaldolase deficiency</p>
          </list-item>
          <list-item>
            <p>
              <related-object link-type="booklink" source-id="gene" document-id="cdg" document-type="chapter">Congenital disorders of glycosylation</related-object>
            </p>
          </list-item>
        </list>
        <p>In addition to HFI, the following disorders should be considered in the evaluation of infants with hyperlacticemia in combination with hypoglycemia:</p>
        <list list-type="bullet">
          <list-item>
            <p>Severe infection/sepsis</p>
          </list-item>
          <list-item>
            <p>Disorders of gluconeogenesis (including 1,6-fructose bisphosphatase and pyruvate dehydrogenase deficiencies)</p>
          </list-item>
          <list-item>
            <p>Fatty acid oxidation disorders (including, <related-object link-type="booklink" source-id="gene" document-id="mcad" document-type="chapter">MCAD deficiency</related-object>, LCHAD deficiency [<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/609016">OMIM</ext-link>], and <related-object link-type="booklink" source-id="gene" document-id="vlcad" document-type="chapter">VLCAD deficiency</related-object>)</p>
          </list-item>
          <list-item>
            <p>Organic acidemias</p>
          </list-item>
          <list-item>
            <p>
              <related-object link-type="booklink" source-id="gene" document-id="mt-overview" document-type="chapter">Mitochondrial disorders</related-object>
            </p>
          </list-item>
          <list-item>
            <p>Disorders of ketone metabolism (including HMG-CoA-lyase deficiency)</p>
          </list-item>
          <list-item>
            <p>Glycogenosis (including glycogen synthase deficiency)</p>
          </list-item>
        </list>
        <p>In addition to HFI, the following disorders should be considered in the evaluation of infants with renal Fanconi/aminoaciduria and failure to thrive:</p>
        <list list-type="bullet">
          <list-item>
            <p>Fanconi-Bickel syndrome (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/227810">OMIM</ext-link>)</p>
          </list-item>
          <list-item>
            <p>Renal tubular acidosis</p>
          </list-item>
          <list-item>
            <p>
              <related-object link-type="booklink" source-id="gene" document-id="mt-overview" document-type="chapter">Mitochondrial disorders</related-object>
            </p>
          </list-item>
          <list-item>
            <p>
              <related-object link-type="booklink" source-id="gene" document-id="cdg" document-type="chapter">Congenital disorders of glycosylation</related-object>
            </p>
          </list-item>
          <list-item>
            <p>
              <related-object link-type="booklink" source-id="gene" document-id="ctns" document-type="chapter">Cystinosis</related-object>
            </p>
          </list-item>
          <list-item>
            <p>
              <related-object link-type="booklink" source-id="gene" document-id="cf" document-type="chapter">Cystic fibrosis</related-object>
            </p>
          </list-item>
        </list>
        <p><bold>Fructose malabsorption</bold> (or &#x0201c;dietary fructose intolerance&#x0201d;), in which fructose transporters in the small intestine are dysfunctional, is distinct from HFI. Symptoms overlap with those observed in HFI and include diarrhea, bloating, and increased flatulence with ingestion of fructose-containing substances. In severe cases, vomiting and abdominal pain may exist, leading to potential confusion with symptoms of HFI. The two disorders can be distinguished clinically by the presence of fructose in the urine in HFI and the presence of fructose in the stool in fructose malabsorption. Hydrogen breath test may be positive in fructose malabsorption; however, this requires oral fructose loading which is potentially hazardous in the setting of true HFI [<xref ref-type="bibr" rid="hfi.REF.m_ller.2003.276">M&#x000fc;ller et al 2003</xref>]. (See <xref ref-type="sec" rid="hfi.AgentsCircumstances_to_Avoid">Agents/Circumstances to Avoid</xref>.)</p>
        <p>Symptoms similar to those of HFI can also be seen in sucrase-isomaltase deficiency (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/222900">OMIM</ext-link>), but simple fructose is well tolerated in that disorder.</p>
        <p>Autoimmune sensitivity to fructose in food protein-induced enterocolitis syndrome (FPIES) has also been reported [<xref ref-type="bibr" rid="hfi.REF.fiocchi.2014.e602">Fiocchi et al 2014</xref>].</p>
        <p><related-object link-type="booklink" source-id="gene" document-id="cdg" document-type="chapter"><bold>Type I congenital disorders of glycosylation</bold></related-object> should be considered in the differential diagnosis of HFI [<xref ref-type="bibr" rid="hfi.REF.adamowicz.2007.407">Adamowicz et al 2007</xref>, <xref ref-type="bibr" rid="hfi.REF.pronicka.2007.101">Pronicka et al 2007</xref>] due in part to the overlap in symptoms (including potential for hepatic insufficiency, failure to thrive, and aminoaciduria/renal Fanconi syndrome), but, more importantly, because HFI causes a secondary disorder of glycosylation [<xref ref-type="bibr" rid="hfi.REF.quintana.2009.s273">Quintana et al 2009</xref>] reflecting inhibitory effects of fructose-1-phosphate on phosphomannose isomerase [<xref ref-type="bibr" rid="hfi.REF.jaeken.1996.764">Jaeken et al 1996</xref>]. In HFI, clinical analysis of transferrin glycosylation may be positive, and should correct once fructose is adequately restricted and liver disease subsides. The pattern of abnormal glycosylation is not characteristic of a particular glycosylation defect, and sequencing of <italic toggle="yes">ALDOB</italic> or enzyme analysis in liver should be considered in instances where there is clinical suspicion for HFI. It should also be noted that in individuals who self-restrict fructose, quantifiable glycosylation abnormalities may resolve spontaneously, and thus transferrin glycosylation should be used with caution and not in isolation in the diagnosis of HFI.</p>
        <p>
          <bold>Other</bold>
        </p>
        <list list-type="bullet">
          <list-item>
            <p>In addition to HFI, the following disorders should be considered in the evaluation of adult- or childhood-onset of chronic liver disease: infection, toxic ingestion, and neoplasm.</p>
          </list-item>
          <list-item>
            <p>In addition to HFI, the following disorders should be considered in the evaluation of infantile/childhood-onset unexplained vomiting: gastroesophageal reflux, pyloric stenosis, <related-object link-type="booklink" source-id="gene" document-id="ucd-overview" document-type="chapter">urea cycle disorders</related-object>, or <related-object link-type="booklink" source-id="gene" document-id="gale-def" document-type="chapter">galactose epimerase deficiency</related-object>.</p>
          </list-item>
          <list-item>
            <p>In children or adults with early-onset and unexplained cataracts, <related-object link-type="booklink" source-id="gene" document-id="ctx" document-type="chapter">cerebrotendinous xanthomatosis</related-object> or galactokinase deficiency (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/230200">OMIM</ext-link>) should be considered.</p>
          </list-item>
          <list-item>
            <p>The co-occurrence of HFI and other conditions (e.g., <related-object link-type="booklink" source-id="gene" document-id="pku" document-type="chapter">phenylketonuria</related-object>, <related-object link-type="booklink" source-id="gene" document-id="celiac" document-type="chapter">celiac disease</related-object>, and <related-object link-type="booklink" source-id="gene" document-id="dbmd" document-type="chapter">Duchenne muscular dystrophy</related-object>) have delayed diagnosis and/or initiation of treatment of HFI in some instances [<xref ref-type="bibr" rid="hfi.REF.celiker.1993.127">Celiker et al 1993</xref>, <xref ref-type="bibr" rid="hfi.REF.ciacci.2006.635">Ciacci et al 2006</xref>, <xref ref-type="bibr" rid="hfi.REF.paolella.2012.64">Paolella et al 2012</xref>].</p>
          </list-item>
        </list>
      </sec>
      <sec id="hfi.Management">
        <title>Management</title>
        <sec id="hfi.Evaluations_Following_Initial_Diagno">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs in an individual diagnosed with hereditary fructose intolerance (HFI), evaluation by the following specialists is recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Biochemical geneticist or pediatrician with an interest in metabolic disorders</p>
            </list-item>
            <list-item>
              <p>Dietician with experience in managing inherited metabolic diseases</p>
            </list-item>
            <list-item>
              <p>Hepatologist</p>
            </list-item>
            <list-item>
              <p>Nephrologist</p>
            </list-item>
            <list-item>
              <p>Clinical geneticist and/or genetic counselor</p>
            </list-item>
          </list>
        </sec>
        <sec id="hfi.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>Acute presentations should be managed symptomatically in a hospital setting, including intravenous glucose (dextrose) administration, supportive treatment of hepatic insufficiency (including fresh frozen plasma or exchange transfusion), and treatment of metabolic acidosis, if present.</p>
          <p>Dietary restriction of fructose, sucrose, and sorbitol is the cornerstone of HFI treatment (see <xref ref-type="sec" rid="hfi.Prevention_of_Primary_Manifestations">Prevention of Primary Manifestations</xref>). During acute episodes of intoxication, including at the time of initial diagnosis, immediate and absolute elimination of fructose (by substitution of fructose with other carbohydrate sources including glucose, maltose, and cornstarch) rapidly reverses symptoms and should result in normalization of related metabolic disturbances.</p>
          <p>Ongoing education for children and adults concerning the need for dietary restriction is recommended, and should ideally be handled by nutritionists with specific experience in treating HFI and other inherited metabolic diseases.</p>
          <p>Individuals with HFI are advised to wear a medically approved alert bracelet/necklace at all times.</p>
          <p>Hepatomegaly with steatosis and lipid vacuolization may remain a persistent complication despite fructose restriction and resolution of initial fibrosis. This includes individuals ascertained by family history and treated from birth [<xref ref-type="bibr" rid="hfi.REF.odi_vre.1978.605">Odi&#x000e8;vre et al 1978</xref>]. The reason for this remains to be determined, but may be related to insufficient fructose restriction as well as lower tolerance of fructose early in life [<xref ref-type="bibr" rid="hfi.REF.froesch.1963.151">Froesch et al 1963</xref>].</p>
          <p>Chronic renal insufficiency, specifically proximal tubular dysfunction, may also persist despite fructose restriction. Typically resolution of renal disease occurs shortly after starting fructose restriction [<xref ref-type="bibr" rid="hfi.REF.odi_vre.1978.605">Odi&#x000e8;vre et al 1978</xref>]. In rare historical instances, dietary modification did not affect renal dysfunction [<xref ref-type="bibr" rid="hfi.REF.mass.1966.516">Mass et al 1966</xref>, <xref ref-type="bibr" rid="hfi.REF.morris.1968.1648">Morris 1968</xref>]. This may be a result of earlier, incomplete attempts at restriction, as reported patients tended to manage themselves with self-restriction alone. It may also be in part due to primary defects in aldolase function and ATPase interaction within the proximal tubule, leading to dysfunctional acid-base regulation, renal tubular insufficiency (manifesting as glucosuria, aminoaciduria, and phosphaturia), and nephrocalcinosis [<xref ref-type="bibr" rid="hfi.REF.mass.1966.516">Mass et al 1966</xref>, <xref ref-type="bibr" rid="hfi.REF.morris.1968.1648">Morris 1968</xref>, <xref ref-type="bibr" rid="hfi.REF.lu.2001.30407">Lu et al 2001</xref>, <xref ref-type="bibr" rid="hfi.REF.steinmann.2011">Steinmann &#x00026; Santer 2011</xref>].</p>
        </sec>
        <sec id="hfi.Prevention_of_Primary_Manifestations">
          <title>Prevention of Primary Manifestations</title>
          <p>Dietary restriction of fructose, sucrose, and sorbitol is necessary for the treatment/management of HFI (<xref ref-type="table" rid="hfi.T.dietary_guidelines_for_hereditary">Table 3</xref>).</p>
          <p>Specific ingredients to avoid include fructose, high-fructose corn syrup, honey, agave syrup, inverted sugar, maple-flavored syrup, molasses, palm or coconut sugar, and sorghum.</p>
          <p>In addition, medicines and formulas in which fructose/sucrose may not be listed as a primary component, examples of which include syrups, enema solutions, some immunoglobulin solutions, and many infant and pediatric nutritional drinks. When ingredients are listed, the terms &#x0201c;sugar,&#x0201d; &#x0201c;table sugar,&#x0201d; &#x0201c;natural flavorings&#x0201d; and even in some cases &#x0201c;sugar-free&#x0201d; or &#x0201c;no added sugar&#x0201d; (with no further clarification on the type of carbohydrate used) should raise suspicion for the presence of fructose, sucrose, or sorbitol.</p>
          <table-wrap id="hfi.T.dietary_guidelines_for_hereditary" position="anchor" orientation="portrait">
            <label>Table 3. </label>
            <caption>
              <p>Dietary Guidelines for Hereditary Fructose Intolerance (HFI)</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_hfi.T.dietary_guidelines_for_hereditary_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Food Category</th>
                  <th id="hd_h_hfi.T.dietary_guidelines_for_hereditary_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Foods Permitted</th>
                  <th id="hd_h_hfi.T.dietary_guidelines_for_hereditary_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Foods Prohibited</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_hfi.T.dietary_guidelines_for_hereditary_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Dairy</bold>
                    <hr/>
                  </td>
                  <td headers="hd_h_hfi.T.dietary_guidelines_for_hereditary_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Any milk, cheese, eggs<hr/></td>
                  <td headers="hd_h_hfi.T.dietary_guidelines_for_hereditary_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Milk products w/added sugar (sweetened yogurt, fruit yogurt, milkshake, chocolate milk)<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_hfi.T.dietary_guidelines_for_hereditary_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Meat</bold>
                    <hr/>
                  </td>
                  <td headers="hd_h_hfi.T.dietary_guidelines_for_hereditary_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Beef, veal, lamb, pork<hr/></td>
                  <td headers="hd_h_hfi.T.dietary_guidelines_for_hereditary_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Ham, bacon, hot dogs, processed meats; any other meat where sugar is used in processing<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_hfi.T.dietary_guidelines_for_hereditary_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Fish</bold>
                    <hr/>
                  </td>
                  <td headers="hd_h_hfi.T.dietary_guidelines_for_hereditary_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">All fish<hr/></td>
                  <td headers="hd_h_hfi.T.dietary_guidelines_for_hereditary_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">None<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_hfi.T.dietary_guidelines_for_hereditary_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Poultry</bold>
                    <hr/>
                  </td>
                  <td headers="hd_h_hfi.T.dietary_guidelines_for_hereditary_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Chicken, turkey<hr/></td>
                  <td headers="hd_h_hfi.T.dietary_guidelines_for_hereditary_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">None<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_hfi.T.dietary_guidelines_for_hereditary_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Cereal</bold>
                    <hr/>
                  </td>
                  <td headers="hd_h_hfi.T.dietary_guidelines_for_hereditary_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Cooked or ready-to-eat cereals (except sweetened &#x00026; sugar-coated cereals)<hr/></td>
                  <td headers="hd_h_hfi.T.dietary_guidelines_for_hereditary_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Sweetened/sugar-coated cereals<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_hfi.T.dietary_guidelines_for_hereditary_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Fruit</bold>
                    <hr/>
                  </td>
                  <td headers="hd_h_hfi.T.dietary_guidelines_for_hereditary_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">None<hr/></td>
                  <td headers="hd_h_hfi.T.dietary_guidelines_for_hereditary_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">All fruits, fruit juices, including squashes &#x00026; cordials, &#x00026; fruit extracts prohibited<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_hfi.T.dietary_guidelines_for_hereditary_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Vegetables</bold>
                    <hr/>
                  </td>
                  <td headers="hd_h_hfi.T.dietary_guidelines_for_hereditary_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Asparagus, cabbage, cauliflower, celery, green beans, green peppers, lettuce, nuts, onions, potatoes, spinach, wax beans<hr/></td>
                  <td headers="hd_h_hfi.T.dietary_guidelines_for_hereditary_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">All other vegetables, including sweet potatoes<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_hfi.T.dietary_guidelines_for_hereditary_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Bread</bold>
                    <hr/>
                  </td>
                  <td headers="hd_h_hfi.T.dietary_guidelines_for_hereditary_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Breads prepared w/out fructose, sucrose, sugar, or sorbitol; soda crackers &#x00026; saltines<hr/></td>
                  <td headers="hd_h_hfi.T.dietary_guidelines_for_hereditary_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Any breads or crackers prepared w/fructose/sucrose/sugar/sorbitol<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_hfi.T.dietary_guidelines_for_hereditary_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Fat sources</bold>
                    <hr/>
                  </td>
                  <td headers="hd_h_hfi.T.dietary_guidelines_for_hereditary_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Butter, margarine, oil, mayonnaise / mustard prepared w/out sugar<hr/></td>
                  <td headers="hd_h_hfi.T.dietary_guidelines_for_hereditary_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Mayonnaises, mustards, &#x00026; salad dressings made with sugar<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_hfi.T.dietary_guidelines_for_hereditary_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Desserts and sweeteners</bold>
                    <hr/>
                  </td>
                  <td headers="hd_h_hfi.T.dietary_guidelines_for_hereditary_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Dietetic jello, dietetic ice cream, dietetic puddings; natural yogurt; glucose, dextrose, dextrin, maltose &#x00026; zero-calorie sweeteners<hr/></td>
                  <td headers="hd_h_hfi.T.dietary_guidelines_for_hereditary_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">All desserts containing sugar (cake, pie, cookies, candy, jello, ice cream, sherbet, honey, fruit juice); sugar, sucrose, sorbitol, fructose<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_hfi.T.dietary_guidelines_for_hereditary_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Miscellaneous</bold>
                  </td>
                  <td headers="hd_h_hfi.T.dietary_guidelines_for_hereditary_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Vegetable juices, coffee, tea, salt, pepper, broths/soups from permitted vegetables; some sugar substitutes; some dietetic beverages; pasta; rice; cinnamon, garlic, poppy seeds; peanut butter (when pure &#x00026; w/out added sugars)</td>
                  <td headers="hd_h_hfi.T.dietary_guidelines_for_hereditary_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Ketchup &#x00026; any other sauces / condiments containing sugar, jam, jelly, preserves, carbonated beverages / soda; peanut butter if prepared w/added sugars; chewing gum w/sorbitol</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn>
                <p>Adapted from <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.bu.edu/aldolase/HFI/treatment/sugar_table.htm">www.bu.edu/aldolase/HFI/treatment/sugar_table.htm</ext-link></p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p>During hospitalizations special caution should be taken to avoid use of fructose-containing intravenous fluids. A number of reported accidental and iatrogenic fructose infusion-related deaths have prompted greater awareness of HFI [<xref ref-type="bibr" rid="hfi.REF.locher.1987.194">Locher 1987</xref>, <xref ref-type="bibr" rid="hfi.REF.sachs.1993.56">Sachs et al 1993</xref>, <xref ref-type="bibr" rid="hfi.REF.curran.2002.112">Curran &#x00026; Havill 2002</xref>, <xref ref-type="bibr" rid="hfi.REF.m_ller.2003.276">M&#x000fc;ller et al 2003</xref>]; however, with a rare disorder such as HFI and in circumstances in which specific dietary (and infusion) restrictions may not be adequately disclosed, the danger of exposure in a hospital setting remains [<xref ref-type="bibr" rid="hfi.REF.cox.1993.413">Cox 1993</xref>]. The following are recommendations:</p>
          <list list-type="bullet">
            <list-item>
              <p>During any hospitalization, all members of the care team should be aware of the diagnosis of HFI and the patient is advised to wear at all times a medically approved alert bracelet/necklace that provides information about the diagnosis of HFI.</p>
            </list-item>
            <list-item>
              <p>&#x02018;Red flags&#x02019; should be placed in the patient&#x02019;s chart or medical record to alert practitioners to the HFI diagnosis and to medical risks associated with exposures to foods and/or medications (oral or parenteral) containing fructose, sucrose, or sorbitol.</p>
            </list-item>
            <list-item>
              <p>Specific medicines known to contain fructose or fructose-like substances should be avoided.</p>
            </list-item>
            <list-item>
              <p>For parenteral medications, hospital pharmacists should be utilized and medications should be cleared for use on a case-by-case basis.</p>
            </list-item>
            <list-item>
              <p>Oral fructose challenge is no longer considered a favorable approach to diagnosis of HFI.</p>
            </list-item>
          </list>
          <p>Dietary restriction should be strictly followed and maintained, especially in infancy. Although some have suggested that after age two years dietary restrictions can be relaxed somewhat [<xref ref-type="bibr" rid="hfi.REF.steinmann.2011">Steinmann &#x00026; Santer 2011</xref>], currently, there are no specific guidelines regarding dietary fructose limits in any age group.</p>
          <p>Tolerance of dietary fructose probably depends on an individual&#x02019;s residual enzyme activity. Furthermore, because actual fructose content in foods may be unreliably reported or difficult to ascertain, adherence to complete dietary restriction of fructose, sucrose, and sorbitol may be difficult attain and unrealistic for some patients with HFI.</p>
        </sec>
        <sec id="hfi.Prevention_of_Secondary_Complication">
          <title>Prevention of Secondary Complications</title>
          <p>Ensuring adequate vitamin supplementation in the setting of reduced fruit and vegetable intake is imperative. Daily supplementation with a &#x0201c;sugar-free&#x0201d; multivitamin is recommended to prevent micronutrient deficiencies, specifically the water-soluble vitamins.</p>
        </sec>
        <sec id="hfi.Surveillance">
          <title>Surveillance</title>
          <p>There are no formal guidelines for surveillance for individuals with HFI (e.g., frequency of subspecialty visits with physicians and/or dieticians with expertise in management of inherited metabolic diseases).</p>
          <p>Once the diagnosis of HFI has been made, periodic evaluation of liver function, renal function, and growth is reasonable, particularly if there are concerns regarding compliance with the fructose/sucrose/sorbitol-restricted diet.</p>
          <p>While isoelectric focusing of transferrin and/or monitoring of aspartylglucosaminidase (elevated in untreated HFI) have been suggested as markers of disease control in HFI, neither of these clinically available tests has definitively proven utility in diagnosis or surveillance [<xref ref-type="bibr" rid="hfi.REF.pronicka.2007.101">Pronicka et al 2007</xref>, <xref ref-type="bibr" rid="hfi.REF.michelakakis.2009.81">Michelakakis et al 2009</xref>, <xref ref-type="bibr" rid="hfi.REF.quintana.2009.s273">Quintana et al 2009</xref>].</p>
        </sec>
        <sec id="hfi.AgentsCircumstances_to_Avoid">
          <title>Agents/Circumstances to Avoid</title>
          <p>Great care should be taken to avoid enteral or parenteral exposure to fructose, sorbitol, sucrose, sucralose, and polysorbate as administration of these substances to individuals with HFI can be fatal.</p>
          <p>The following resources can be valuable in determining medical and dietary safety.</p>
          <list list-type="bullet">
            <list-item>
              <p>Dietary guidance &#x02013;including prohibited foods- is outlined in <xref ref-type="table" rid="hfi.T.dietary_guidelines_for_hereditary">Table 3</xref>.</p>
            </list-item>
            <list-item>
              <p>An extensive list of tolerated and non-tolerated sugars in HFI can be found <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.bu.edu/aldolase/HFI/treatment/index.html">online</ext-link>, a site curated by the Boston University HFI laboratory.</p>
            </list-item>
            <list-item>
              <p>Although there is no single consolidated list of medications that contain these or related sugars, an advanced search on <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.medicines.org.uk">www.medicines.org.uk</ext-link> using the search term &#x0201c;fructose OR sorbitol OR sucrose OR sucralose&#x0201d; yielded 1776 results. Many such medications are oral suspensions or chewable flavored tabs designed for pediatric use. Also listed were injectable medications like immunoglobulin solutions (e.g., trastuzumab, filgrastim, some intravenous immunoglobulin solutions), vaccines (e.g., certain influenza, meningococcal), and iron supplements, as well as enema solutions and rinsing aids. For many preparations, it may not be apparent that fructose or similar compounds are present.</p>
            </list-item>
            <list-item>
              <p>For parenteral medications, hospital pharmacists should clear use of medications on a case-by-case basis. Of particular note, a 24% sucrose solution (routinely administered to hospitalized neonates for minor procedures) <bold>should</bold>
<bold>not be given</bold> to neonates known to have HFI.</p>
            </list-item>
            <list-item>
              <p>The fructose tolerance testing (&#x02018;fructose challenge&#x02019;) to diagnose HFI can be hazardous and should not be used.</p>
            </list-item>
          </list>
        </sec>
        <sec id="hfi.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>It may be appropriate to evaluate apparently asymptomatic older and younger sibs in order to identify individuals who would benefit from fructose restriction (see <xref ref-type="sec" rid="hfi.Prevention_of_Primary_Manifestations">Prevention of Primary Manifestations</xref>). If the <italic toggle="yes">ALDOB</italic> pathogenic variants in the family are known, targeted molecular genetic testing can be used to clarify the genetic status of at-risk family members.</p>
          <p>See <xref ref-type="sec" rid="hfi.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="hfi.Pregnancy_Management">
          <title>Pregnancy Management</title>
          <p>Few reports exist relating to management of pregnant women with HFI or pregnancy-related complications in HFI. In general, in familial reports in which pregnancies are not expressly discussed, it appears that HFI in a pregnant mother does not cause harm to the mother or the child provided that strict fructose avoidance is followed during the pregnancy.</p>
          <p>In one family a woman with enzymatically documented HFI had three children (presumably from the same father), all of whom also had HFI [<xref ref-type="bibr" rid="hfi.REF.marks.1989.362">Marks et al 1989</xref>]. Most complications observed in these children seem to have resulted from their own poorly controlled HFI or comorbidities in early childhood, rather than maternal effects of HFI per se. The first child developed failure to thrive and cirrhosis and died at age six months of <italic toggle="yes">E. coli</italic> sepsis and pulmonary edema. The second child, who had HFI complicated by transfusion-acquired HIV infection, died at age five years from complications of acquired immunodeficiency syndrome (AIDS). In her third pregnancy, which proceeded normally, the mother was maintained on a strict fructose-restricted diet. The child also had HFI but thrived on a fructose-restricted diet.</p>
        </sec>
        <sec id="hfi.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions.</p>
        </sec>
      </sec>
      <sec id="hfi.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="hfi.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>Hereditary fructose intolerance (HFI) is inherited in an autosomal recessive manner.</p>
        </sec>
        <sec id="hfi.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The parents of an affected individual are obligate heterozygotes (i.e., carriers of one <italic toggle="yes">ALDOB</italic> pathogenic variant).</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are generally asymptomatic and are not at risk of developing HFI (see <xref ref-type="sec" rid="hfi.Clinical_Description">Clinical Description</xref>, <bold>Heterozygotes</bold>).</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being a carrier, and a 25% chance of being unaffected and not a carrier.</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are asymptomatic and are not at risk of developing HFI (see <xref ref-type="sec" rid="hfi.Clinical_Description">Clinical Description</xref>, <bold>Heterozygotes</bold>).</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> Unless an individual with HFI has children with an affected individual or a carrier, his/her offspring will be obligate heterozygotes (carriers) for a pathogenic variant in <italic toggle="yes">ALDOB</italic> (see <xref ref-type="sec" rid="hfi.Clinical_Description">Clinical Description</xref>, <bold>Heterozygotes</bold>).</p>
          <p><bold>Other family members.</bold> Each sib of the proband&#x02019;s parents is at a 50% risk of being a carrier of an <italic toggle="yes">ALDOB</italic> pathogenic variant.</p>
        </sec>
        <sec id="hfi.Carrier_Heterozygote_Detection">
          <title>Carrier (Heterozygote) Detection</title>
          <p>Carrier testing for at-risk relatives requires prior identification of the <italic toggle="yes">ALDOB</italic> pathogenic variants in the family.</p>
        </sec>
        <sec id="hfi.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p>See Management, <xref ref-type="sec" rid="hfi.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</xref> for information on evaluating at-risk sibs for the purpose of early diagnosis and treatment.</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk, clarification of carrier status, and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected, are carriers, or are at risk of being carriers.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="hfi.Prenatal_Testing_and_Preimplantation">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p>Once the <italic toggle="yes">ALDOB</italic> pathogenic variants have been identified in an affected family member, prenatal testing and preimplantation genetic diagnosis for a pregnancy at increased risk for HFI are possible options.</p>
          <p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. Although most centers would consider decisions about prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p>
        </sec>
      </sec>
      <sec id="hfi.Resources">
        <title>Resources</title>
      </sec>
      <sec id="hfi.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <p><bold>Gene structure.</bold>
<italic toggle="yes">ALDOB</italic> has nine exons and spans a DNA segment of 14.5 kb. ALDOB mRNA encodes a 364-amino acid polypeptide; 5' flanking sequences (up to 200 base pairs) of <italic toggle="yes">ALDOB</italic> from different species are highly conserved. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="hfi" object-id="hfi.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
        <p><bold>Pathogenic allelic variants.</bold> Approximately 60 different <italic toggle="yes">ALDOB</italic> pathogenic variants have been described and are cataloged in the Human Gene Mutation Database (HGMD). Types of pathogenic variants include missense, nonsense, and splice-site variants, small insertions and deletions that result in a shift of the reading frame, and several large deletions (see <xref ref-type="table" rid="hfi.T.aldob_pathogenic_variants_discusse">Table 4</xref>).</p>
        <p>The spectrum and allele frequency of various pathogenic <italic toggle="yes">ALDOB</italic> alleles has been described mostly in European and North American populations with HFI [<xref ref-type="bibr" rid="hfi.REF.s_nchezguti_rrez.2002.e56">S&#x000e1;nchez-Guti&#x000e9;rrez et al 2002</xref>, <xref ref-type="bibr" rid="hfi.REF.santer.2005.594">Santer et al 2005</xref>, <xref ref-type="bibr" rid="hfi.REF.gruchota.2006.376">Gruchota et al 2006</xref>, <xref ref-type="bibr" rid="hfi.REF.davitspraul.2008.443">Davit-Spraul et al 2008</xref>, <xref ref-type="bibr" rid="hfi.REF.coffee.2010.33">Coffee et al 2010</xref>, <xref ref-type="bibr" rid="hfi.REF.ferri.2012.31">Ferri et al 2012</xref>]:</p>
        <list list-type="bullet">
          <list-item>
            <p>p.Ala150Pro: 44%-67%</p>
          </list-item>
          <list-item>
            <p>p.Ala175Asp: 0%-19%</p>
          </list-item>
          <list-item>
            <p>p.Asn335Lys: 0%-8%</p>
          </list-item>
          <list-item>
            <p>p.Arg60Ter: 0%-4%</p>
          </list-item>
          <list-item>
            <p>p.Asn120LysfsTer32 (&#x0201c;delta E4E&#x0201d; allele): 4%</p>
          </list-item>
          <list-item>
            <p>6.5-kb intragenic deletion: 11% allele frequency in Italians</p>
          </list-item>
        </list>
        <p>The c.324+1G&#x0003e;A splicing variant accounted for 59% of <italic toggle="yes">ALDOB</italic> pathogenic variants in a small cohort of North Indian patients diagnosed and managed in New Delhi. Several other novel pathogenic variants were also reported in this population [<xref ref-type="bibr" rid="hfi.REF.bijarniamahay.2015.85">Bijarnia-Mahay et al 2015</xref>].</p>
        <table-wrap id="hfi.T.aldob_pathogenic_variants_discusse" position="anchor" orientation="portrait">
          <label>Table 4. </label>
          <caption>
            <p><italic toggle="yes">ALDOB</italic> Pathogenic Variants Discussed in This <italic toggle="yes">GeneReview</italic></p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_hfi.T.aldob_pathogenic_variants_discusse_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                <th id="hd_h_hfi.T.aldob_pathogenic_variants_discusse_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change<break/>(Alias)&#x000a0;<sup>1</sup></th>
                <th id="hd_h_hfi.T.aldob_pathogenic_variants_discusse_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_hfi.T.aldob_pathogenic_variants_discusse_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.178C&#x0003e;T<hr/></td>
                <td headers="hd_h_hfi.T.aldob_pathogenic_variants_discusse_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg60Ter<hr/></td>
                <td headers="hd_h_hfi.T.aldob_pathogenic_variants_discusse_1_1_1_3" rowspan="7" valign="middle" align="left" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_000035.3">NM_000035.3</ext-link>
                  <break/>
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_000026.2">NP_000026.2</ext-link>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_hfi.T.aldob_pathogenic_variants_discusse_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.324+1G&#x0003e;A<hr/></td>
                <td headers="hd_h_hfi.T.aldob_pathogenic_variants_discusse_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">--<hr/></td>
              </tr>
              <tr>
                <td headers="hd_h_hfi.T.aldob_pathogenic_variants_discusse_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.360_363delCAAA<hr/></td>
                <td headers="hd_h_hfi.T.aldob_pathogenic_variants_discusse_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Asn120LysfsTer32 <break/>(delta E4E)<hr/></td>
              </tr>
              <tr>
                <td headers="hd_h_hfi.T.aldob_pathogenic_variants_discusse_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.448G&#x0003e;C<hr/></td>
                <td headers="hd_h_hfi.T.aldob_pathogenic_variants_discusse_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Ala150Pro<hr/></td>
              </tr>
              <tr>
                <td headers="hd_h_hfi.T.aldob_pathogenic_variants_discusse_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.524C&#x0003e;A<hr/></td>
                <td headers="hd_h_hfi.T.aldob_pathogenic_variants_discusse_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Ala175Asp<hr/></td>
              </tr>
              <tr>
                <td headers="hd_h_hfi.T.aldob_pathogenic_variants_discusse_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.865delC<hr/></td>
                <td headers="hd_h_hfi.T.aldob_pathogenic_variants_discusse_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Leu288PhefsTer10<hr/></td>
              </tr>
              <tr>
                <td headers="hd_h_hfi.T.aldob_pathogenic_variants_discusse_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1005C&#x0003e;G</td>
                <td headers="hd_h_hfi.T.aldob_pathogenic_variants_discusse_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p. Asn335Lys</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>Note on variant classification: Variants listed in the table have been provided by the authors.&#x000a0;<italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
            </fn>
            <fn>
              <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
            </fn>
            <fn id="hfi.TF.4.1">
              <label>1. </label>
              <p>Variant designation that does not conform to current naming conventions</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p><bold>Normal gene product.</bold> Functional aldolase B enzyme (the protein product of <italic toggle="yes">ALDOB</italic>) is a 160-kd tetramer consisting of four identical subunits; it has similar activity with fructose 1,6 bisphosphate and fructose 1-phosphate. The single primary transcript undergoes alternative splicing to give rise to the three isozyme-specific aldolases with variable carboxy-terminal sequencing and differing catalytic properties [<xref ref-type="bibr" rid="hfi.REF.ali.1998.353">Ali et al 1998</xref>]. Together with fructokinase and triokinase, aldolase B participates in fructose metabolism, mostly in the liver, renal cortex, and intestinal mucosa. Aldolase B splits fructose-1-phosphate into dihydroxyacetone phosphate and glyceraldehyde. Hepatic formation of glycogen from fructose is principally catalyzed by aldolase B.</p>
        <p>In normal individuals, aldolase B rapidly converts intravenous fructose to glucose resulting in hyperglycemia; fructose may also be converted to lactate, provoking metabolic acidosis. For these reasons, the use of fructose, sucrose, or sorbitol has been discouraged as a constituent of parenteral nutrition in general.</p>
        <p><bold>Abnormal gene product.</bold> HFI results from loss of aldolase B function. The p.Ala150Pro pathogenic variant is known to be more thermolabile than the wild-type protein [<xref ref-type="bibr" rid="hfi.REF.malay.2005.135">Malay et al 2005</xref>]. Partial misfolding with consequent loss of activity is a common feature in inherited metabolic diseases. Accumulation of fructose-1-phosphate in the setting of diminished aldolase B function inhibits gluconeogenesis and glycogenolysis, causes overutilization and diminished regeneration of ATP, and impairs protein glycosylation.</p>
      </sec>
      <sec id="hfi.References">
        <title>References</title>
        <ref-list id="hfi.References.reflist0">
          <ref id="hfi.REF.adamowicz.2007.407">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Adamowicz</surname>
                  <given-names>M</given-names>
                </name>
                <name name-style="western">
                  <surname>P&#x00142;oski</surname>
                  <given-names>R</given-names>
                </name>
                <name name-style="western">
                  <surname>Rokicki</surname>
                  <given-names>D</given-names>
                </name>
                <name name-style="western">
                  <surname>Morava</surname>
                  <given-names>E</given-names>
                </name>
                <name name-style="western">
                  <surname>Gizewska</surname>
                  <given-names>M</given-names>
                </name>
                <name name-style="western">
                  <surname>Mierzewska</surname>
                  <given-names>H</given-names>
                </name>
                <name name-style="western">
                  <surname>Pollak</surname>
                  <given-names>A</given-names>
                </name>
                <name name-style="western">
                  <surname>Lefeber</surname>
                  <given-names>DJ</given-names>
                </name>
                <name name-style="western">
                  <surname>Wevers</surname>
                  <given-names>RA</given-names>
                </name>
                <name name-style="western">
                  <surname>Pronicka</surname>
                  <given-names>E</given-names>
                </name>
              </person-group>
              <article-title>Transferrin hypoglycosylation in hereditary fructose intolerance: using the clues and avoiding the pitfalls.</article-title>
              <source>J Inherit Metab Dis.</source>
              <year>2007</year>
              <volume>30</volume>
              <fpage>407</fpage>
              <pub-id pub-id-type="pmid">17457694</pub-id>
            </element-citation>
          </ref>
          <ref id="hfi.REF.ali.1998.353">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Ali</surname>
                  <given-names>M</given-names>
                </name>
                <name name-style="western">
                  <surname>Rellos</surname>
                  <given-names>P</given-names>
                </name>
                <name name-style="western">
                  <surname>Cox</surname>
                  <given-names>TM</given-names>
                </name>
              </person-group>
              <article-title>Hereditary fructose intolerance.</article-title>
              <source>J Med Genet</source>
              <year>1998</year>
              <volume>35</volume>
              <fpage>353</fpage>
              <lpage>65</lpage>
              <pub-id pub-id-type="pmid">9610797</pub-id>
            </element-citation>
          </ref>
          <ref id="hfi.REF.ananth.2003.87">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Ananth</surname>
                  <given-names>N</given-names>
                </name>
                <name name-style="western">
                  <surname>Praveenkumar</surname>
                  <given-names>GS</given-names>
                </name>
                <name name-style="western">
                  <surname>Rao</surname>
                  <given-names>KA</given-names>
                </name>
              </person-group>
              <article-title>Vasanthi, Kakkilaya S. Two cases of hereditary fructose intolerance.</article-title>
              <source>Indian J Clin Biochem.</source>
              <year>2003</year>
              <volume>18</volume>
              <fpage>87</fpage>
              <lpage>92</lpage>
              <pub-id pub-id-type="pmid">23105397</pub-id>
            </element-citation>
          </ref>
          <ref id="hfi.REF.bijarniamahay.2015.85">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Bijarnia-Mahay</surname>
                  <given-names>S</given-names>
                </name>
                <name name-style="western">
                  <surname>Movva</surname>
                  <given-names>S</given-names>
                </name>
                <name name-style="western">
                  <surname>Gupta</surname>
                  <given-names>N</given-names>
                </name>
                <name name-style="western">
                  <surname>Sharma</surname>
                  <given-names>D</given-names>
                </name>
                <name name-style="western">
                  <surname>Puri</surname>
                  <given-names>RD</given-names>
                </name>
                <name name-style="western">
                  <surname>Kotecha</surname>
                  <given-names>U</given-names>
                </name>
                <name name-style="western">
                  <surname>Saxena</surname>
                  <given-names>R</given-names>
                </name>
                <name name-style="western">
                  <surname>Kabra</surname>
                  <given-names>M</given-names>
                </name>
                <name name-style="western">
                  <surname>Mohan</surname>
                  <given-names>N</given-names>
                </name>
                <name name-style="western">
                  <surname>Verma</surname>
                  <given-names>IC</given-names>
                </name>
              </person-group>
              <article-title>Molecular diagnosis of hereditary fructose intolerance: founder mutation in a community from India.</article-title>
              <source>JIMD Rep.</source>
              <year>2015</year>
              <volume>19</volume>
              <fpage>85</fpage>
              <lpage>93</lpage>
              <pub-id pub-id-type="pmid">25595217</pub-id>
            </element-citation>
          </ref>
          <ref id="hfi.REF.bouteldja.2010.105">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Bouteldja</surname>
                  <given-names>N</given-names>
                </name>
                <name name-style="western">
                  <surname>Timson</surname>
                  <given-names>DJ</given-names>
                </name>
              </person-group>
              <article-title>The biochemical basis of hereditary fructose intolerance.</article-title>
              <source>J Inherit Metab Dis.</source>
              <year>2010</year>
              <volume>33</volume>
              <fpage>105</fpage>
              <lpage>12</lpage>
              <pub-id pub-id-type="pmid">20162364</pub-id>
            </element-citation>
          </ref>
          <ref id="hfi.REF.celiker.1993.127">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Celiker</surname>
                  <given-names>V</given-names>
                </name>
                <name name-style="western">
                  <surname>Dural</surname>
                  <given-names>O</given-names>
                </name>
                <name name-style="western">
                  <surname>Erdem</surname>
                  <given-names>K</given-names>
                </name>
              </person-group>
              <article-title>Anesthetic management of a patient with hereditary fructose intolerance and phenylketonuria.</article-title>
              <source>Turk J Pediatr.</source>
              <year>1993</year>
              <volume>35</volume>
              <fpage>127</fpage>
              <lpage>30</lpage>
              <pub-id pub-id-type="pmid">8249192</pub-id>
            </element-citation>
          </ref>
          <ref id="hfi.REF.chambers.1956.340">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Chambers</surname>
                  <given-names>RA</given-names>
                </name>
                <name name-style="western">
                  <surname>Pratt</surname>
                  <given-names>RT</given-names>
                </name>
              </person-group>
              <article-title>Idiosyncrasy to fructose.</article-title>
              <source>Lancet.</source>
              <year>1956</year>
              <volume>271</volume>
              <fpage>340</fpage>
              <pub-id pub-id-type="pmid">13358219</pub-id>
            </element-citation>
          </ref>
          <ref id="hfi.REF.ciacci.2006.635">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Ciacci</surname>
                  <given-names>C</given-names>
                </name>
                <name name-style="western">
                  <surname>Gennarelli</surname>
                  <given-names>D</given-names>
                </name>
                <name name-style="western">
                  <surname>Esposito</surname>
                  <given-names>G</given-names>
                </name>
                <name name-style="western">
                  <surname>Tortora</surname>
                  <given-names>R</given-names>
                </name>
                <name name-style="western">
                  <surname>Salvatore</surname>
                  <given-names>F</given-names>
                </name>
                <name name-style="western">
                  <surname>Sacchetti</surname>
                  <given-names>L</given-names>
                </name>
              </person-group>
              <article-title>Hereditary fructose intolerance and celiac disease: a novel genetic association.</article-title>
              <source>Clin Gastroenterol Hepatol.</source>
              <year>2006</year>
              <volume>4</volume>
              <fpage>635</fpage>
              <lpage>8</lpage>
              <pub-id pub-id-type="pmid">16630753</pub-id>
            </element-citation>
          </ref>
          <ref id="hfi.REF.coffee.2010.33">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Coffee</surname>
                  <given-names>EM</given-names>
                </name>
                <name name-style="western">
                  <surname>Yerkes</surname>
                  <given-names>L</given-names>
                </name>
                <name name-style="western">
                  <surname>Ewen</surname>
                  <given-names>EP</given-names>
                </name>
                <name name-style="western">
                  <surname>Zee</surname>
                  <given-names>T</given-names>
                </name>
                <name name-style="western">
                  <surname>Tolan</surname>
                  <given-names>DR</given-names>
                </name>
              </person-group>
              <article-title>Increased prevalence of mutant null alleles that cause hereditary fructose intolerance in the American population.</article-title>
              <source>J Inherit Metab Dis.</source>
              <year>2010</year>
              <volume>33</volume>
              <fpage>33</fpage>
              <lpage>42</lpage>
              <pub-id pub-id-type="pmid">20033295</pub-id>
            </element-citation>
          </ref>
          <ref id="hfi.REF.cox.1993.413">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Cox</surname>
                  <given-names>TM</given-names>
                </name>
              </person-group>
              <article-title>Iatrogenic deaths in hereditary fructose intolerance.</article-title>
              <source>Arch Dis Child.</source>
              <year>1993</year>
              <volume>69</volume>
              <fpage>413</fpage>
              <lpage>5</lpage>
              <pub-id pub-id-type="pmid">8259868</pub-id>
            </element-citation>
          </ref>
          <ref id="hfi.REF.cross.1990.101">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Cross</surname>
                  <given-names>NC</given-names>
                </name>
                <name name-style="western">
                  <surname>Cox</surname>
                  <given-names>TM</given-names>
                </name>
              </person-group>
              <article-title>Partial aldolase B gene deletions in hereditary fructose intolerance.</article-title>
              <source>Am J Hum Genet.</source>
              <year>1990</year>
              <volume>47</volume>
              <fpage>101</fpage>
              <lpage>6</lpage>
              <pub-id pub-id-type="pmid">2349937</pub-id>
            </element-citation>
          </ref>
          <ref id="hfi.REF.curran.2002.112">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Curran</surname>
                  <given-names>BJ</given-names>
                </name>
                <name name-style="western">
                  <surname>Havill</surname>
                  <given-names>JH</given-names>
                </name>
              </person-group>
              <article-title>Hepatic and renal failure associated with amiodarone infusion in a patient with hereditary fructose intolerance.</article-title>
              <source>Crit Care Resusc.</source>
              <year>2002</year>
              <volume>4</volume>
              <fpage>112</fpage>
              <lpage>5</lpage>
              <pub-id pub-id-type="pmid">16573414</pub-id>
            </element-citation>
          </ref>
          <ref id="hfi.REF.davitspraul.2008.443">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Davit-Spraul</surname>
                  <given-names>A</given-names>
                </name>
                <name name-style="western">
                  <surname>Costa</surname>
                  <given-names>C</given-names>
                </name>
                <name name-style="western">
                  <surname>Zater</surname>
                  <given-names>M</given-names>
                </name>
                <name name-style="western">
                  <surname>Habes</surname>
                  <given-names>D</given-names>
                </name>
                <name name-style="western">
                  <surname>Berthelot</surname>
                  <given-names>J</given-names>
                </name>
                <name name-style="western">
                  <surname>Brou&#x000e9;</surname>
                  <given-names>P</given-names>
                </name>
                <name name-style="western">
                  <surname>Feillet</surname>
                  <given-names>F</given-names>
                </name>
                <name name-style="western">
                  <surname>Bernard</surname>
                  <given-names>O</given-names>
                </name>
                <name name-style="western">
                  <surname>Labrune</surname>
                  <given-names>P</given-names>
                </name>
                <name name-style="western">
                  <surname>Baussan</surname>
                  <given-names>C.</given-names>
                </name>
              </person-group>
              <article-title>Hereditary fructose intolerance: frequency and spectrum mutations of the aldolase B gene in a large patients cohort from France &#x02013; identification of eight new mutations.</article-title>
              <source>Mol Genet Metab</source>
              <year>2008</year>
              <volume>94</volume>
              <fpage>443</fpage>
              <lpage>7</lpage>
              <pub-id pub-id-type="pmid">18541450</pub-id>
            </element-citation>
          </ref>
          <ref id="hfi.REF.dursun.2001.523">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Dursun</surname>
                  <given-names>A</given-names>
                </name>
                <name name-style="western">
                  <surname>Kalkano&#x0011f;lu</surname>
                  <given-names>HS</given-names>
                </name>
                <name name-style="western">
                  <surname>Co&#x0015f;kun</surname>
                  <given-names>T</given-names>
                </name>
                <name name-style="western">
                  <surname>Tokatli</surname>
                  <given-names>A</given-names>
                </name>
                <name name-style="western">
                  <surname>Bittner</surname>
                  <given-names>R</given-names>
                </name>
                <name name-style="western">
                  <surname>Ko&#x000e7;ak</surname>
                  <given-names>N</given-names>
                </name>
                <name name-style="western">
                  <surname>Y&#x000fc;ce</surname>
                  <given-names>A</given-names>
                </name>
                <name name-style="western">
                  <surname>Ozalp</surname>
                  <given-names>I</given-names>
                </name>
                <name name-style="western">
                  <surname>Boehme</surname>
                  <given-names>HJ</given-names>
                </name>
              </person-group>
              <article-title>Mutation analysis in Turkish patients with hereditary fructose intolerance.</article-title>
              <source>J Inherit Metab Dis.</source>
              <year>2001</year>
              <volume>24</volume>
              <fpage>523</fpage>
              <lpage>6</lpage>
              <pub-id pub-id-type="pmid">11757579</pub-id>
            </element-citation>
          </ref>
          <ref id="hfi.REF.esposito.2010.1294">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Esposito</surname>
                  <given-names>G</given-names>
                </name>
                <name name-style="western">
                  <surname>Imperato</surname>
                  <given-names>MR</given-names>
                </name>
                <name name-style="western">
                  <surname>Ieno</surname>
                  <given-names>L</given-names>
                </name>
                <name name-style="western">
                  <surname>Sorvillo</surname>
                  <given-names>R</given-names>
                </name>
                <name name-style="western">
                  <surname>Benigno</surname>
                  <given-names>V</given-names>
                </name>
                <name name-style="western">
                  <surname>Parenti</surname>
                  <given-names>G</given-names>
                </name>
                <name name-style="western">
                  <surname>Parini</surname>
                  <given-names>R</given-names>
                </name>
                <name name-style="western">
                  <surname>Vitagliano</surname>
                  <given-names>L</given-names>
                </name>
                <name name-style="western">
                  <surname>Zagari</surname>
                  <given-names>A</given-names>
                </name>
                <name name-style="western">
                  <surname>Salvatore</surname>
                  <given-names>F</given-names>
                </name>
              </person-group>
              <article-title>Hereditary fructose intolerance: functional study of two novel ALDOB natural variants and characterization of a partial gene deletion.</article-title>
              <source>Hum Mutat</source>
              <year>2010</year>
              <volume>31</volume>
              <fpage>1294</fpage>
              <lpage>303</lpage>
              <pub-id pub-id-type="pmid">20848650</pub-id>
            </element-citation>
          </ref>
          <ref id="hfi.REF.ferri.2012.31">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Ferri</surname>
                  <given-names>L</given-names>
                </name>
                <name name-style="western">
                  <surname>Caciotti</surname>
                  <given-names>A</given-names>
                </name>
                <name name-style="western">
                  <surname>Cavicchi</surname>
                  <given-names>C</given-names>
                </name>
                <name name-style="western">
                  <surname>Rigoldi</surname>
                  <given-names>M</given-names>
                </name>
                <name name-style="western">
                  <surname>Parini</surname>
                  <given-names>R</given-names>
                </name>
                <name name-style="western">
                  <surname>Caserta</surname>
                  <given-names>M</given-names>
                </name>
                <name name-style="western">
                  <surname>Chibbaro</surname>
                  <given-names>G</given-names>
                </name>
                <name name-style="western">
                  <surname>Gasperini</surname>
                  <given-names>S</given-names>
                </name>
                <name name-style="western">
                  <surname>Procopio</surname>
                  <given-names>E</given-names>
                </name>
                <name name-style="western">
                  <surname>Donati</surname>
                  <given-names>MA</given-names>
                </name>
                <name name-style="western">
                  <surname>Guerrini</surname>
                  <given-names>R</given-names>
                </name>
                <name name-style="western">
                  <surname>Morrone</surname>
                  <given-names>A</given-names>
                </name>
              </person-group>
              <article-title>Integration of PCR-sequencing analysis with multiplex ligation-dependent probe amplification for diagnosis of hereditary fructose intolerance.</article-title>
              <source>JIMD Rep.</source>
              <year>2012</year>
              <volume>6</volume>
              <fpage>31</fpage>
              <lpage>7</lpage>
              <pub-id pub-id-type="pmid">23430936</pub-id>
            </element-citation>
          </ref>
          <ref id="hfi.REF.fiocchi.2014.e602">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Fiocchi</surname>
                  <given-names>A</given-names>
                </name>
                <name name-style="western">
                  <surname>Dionisi-Vici</surname>
                  <given-names>C</given-names>
                </name>
                <name name-style="western">
                  <surname>Cotugno</surname>
                  <given-names>G</given-names>
                </name>
                <name name-style="western">
                  <surname>Koch</surname>
                  <given-names>P</given-names>
                </name>
                <name name-style="western">
                  <surname>Dahdah</surname>
                  <given-names>L.</given-names>
                </name>
              </person-group>
              <article-title>Fruit-induced FPIES masquerading as hereditary fructose intolerance.</article-title>
              <source>Pediatrics.</source>
              <year>2014</year>
              <volume>134</volume>
              <fpage>e602</fpage>
              <lpage>5</lpage>
              <pub-id pub-id-type="pmid">25002667</pub-id>
            </element-citation>
          </ref>
          <ref id="hfi.REF.froesch.1963.151">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Froesch</surname>
                  <given-names>ER</given-names>
                </name>
                <name name-style="western">
                  <surname>Wolf</surname>
                  <given-names>HP</given-names>
                </name>
                <name name-style="western">
                  <surname>Baitsch</surname>
                  <given-names>H</given-names>
                </name>
                <name name-style="western">
                  <surname>Prader</surname>
                  <given-names>A</given-names>
                </name>
                <name name-style="western">
                  <surname>Labhart</surname>
                  <given-names>A.</given-names>
                </name>
              </person-group>
              <article-title>Hereditary fructose intolerance. An inborn defect of hepatic fructose-1-phosphate splitting aldolase.</article-title>
              <source>Am J Med.</source>
              <year>1963</year>
              <volume>34</volume>
              <fpage>151</fpage>
              <lpage>67</lpage>
              <pub-id pub-id-type="pmid">13959929</pub-id>
            </element-citation>
          </ref>
          <ref id="hfi.REF.gruchota.2006.376">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Gruchota</surname>
                  <given-names>J</given-names>
                </name>
                <name name-style="western">
                  <surname>Pronicka</surname>
                  <given-names>E</given-names>
                </name>
                <name name-style="western">
                  <surname>Korniszewski</surname>
                  <given-names>L</given-names>
                </name>
                <name name-style="western">
                  <surname>Stolarski</surname>
                  <given-names>B</given-names>
                </name>
                <name name-style="western">
                  <surname>Pollak</surname>
                  <given-names>A</given-names>
                </name>
                <name name-style="western">
                  <surname>Rogaszewska</surname>
                  <given-names>M</given-names>
                </name>
                <name name-style="western">
                  <surname>P&#x00142;oski</surname>
                  <given-names>R.</given-names>
                </name>
              </person-group>
              <article-title>Aldolase B mutations and prevalence of hereditary fructose intolerance in a Polish population.</article-title>
              <source>Mol Genet Metab.</source>
              <year>2006</year>
              <volume>87</volume>
              <fpage>376</fpage>
              <lpage>8</lpage>
              <pub-id pub-id-type="pmid">16406649</pub-id>
            </element-citation>
          </ref>
          <ref id="hfi.REF.hommes.1993.788s">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Hommes</surname>
                  <given-names>FA</given-names>
                </name>
              </person-group>
              <article-title>Inborn errors of fructose metabolism.</article-title>
              <source>Am J Clin Nutr.</source>
              <year>1993</year>
              <volume>58</volume>
              <fpage>788S</fpage>
              <lpage>95S</lpage>
              <pub-id pub-id-type="pmid">8213611</pub-id>
            </element-citation>
          </ref>
          <ref id="hfi.REF.hoskov_.1977.63">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Hoskov&#x000e1;</surname>
                  <given-names>A</given-names>
                </name>
                <name name-style="western">
                  <surname>Mrskos</surname>
                  <given-names>A</given-names>
                </name>
              </person-group>
              <article-title>Haemorrhagic diathesis as a possible early sign of hereditary fructose intolerance.</article-title>
              <source>Eur J Pediatr.</source>
              <year>1977</year>
              <volume>127</volume>
              <fpage>63</fpage>
              <lpage>5</lpage>
              <pub-id pub-id-type="pmid">606560</pub-id>
            </element-citation>
          </ref>
          <ref id="hfi.REF.jaeken.1996.764">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Jaeken</surname>
                  <given-names>J</given-names>
                </name>
                <name name-style="western">
                  <surname>Pirard</surname>
                  <given-names>M</given-names>
                </name>
                <name name-style="western">
                  <surname>Adamowicz</surname>
                  <given-names>M</given-names>
                </name>
                <name name-style="western">
                  <surname>Pronicka</surname>
                  <given-names>E</given-names>
                </name>
                <name name-style="western">
                  <surname>van Schaftingen</surname>
                  <given-names>E</given-names>
                </name>
              </person-group>
              <article-title>Inhibition of phosphomannose isomerase by fructose 1-phosphate: an explanation for defective N-glycosylation in hereditary fructose intolerance.</article-title>
              <source>Pediatr Res.</source>
              <year>1996</year>
              <volume>40</volume>
              <fpage>764</fpage>
              <lpage>6</lpage>
              <pub-id pub-id-type="pmid">8910943</pub-id>
            </element-citation>
          </ref>
          <ref id="hfi.REF.james.1996.837">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>James</surname>
                  <given-names>CL</given-names>
                </name>
                <name name-style="western">
                  <surname>Rellos</surname>
                  <given-names>P</given-names>
                </name>
                <name name-style="western">
                  <surname>Ali</surname>
                  <given-names>M</given-names>
                </name>
                <name name-style="western">
                  <surname>Heeley</surname>
                  <given-names>AF</given-names>
                </name>
                <name name-style="western">
                  <surname>Cox</surname>
                  <given-names>TM</given-names>
                </name>
              </person-group>
              <article-title>Neonatal screening for hereditary fructose intolerance: frequency of the most common mutant aldolase B allele (A149P) in the British population.</article-title>
              <source>J Med Genet.</source>
              <year>1996</year>
              <volume>33</volume>
              <fpage>837</fpage>
              <lpage>41</lpage>
              <pub-id pub-id-type="pmid">8933337</pub-id>
            </element-citation>
          </ref>
          <ref id="hfi.REF.krawczy_ski.1994.702">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Krawczy&#x00144;ski</surname>
                  <given-names>M</given-names>
                </name>
                <name name-style="western">
                  <surname>Targo&#x00144;ska</surname>
                  <given-names>B</given-names>
                </name>
                <name name-style="western">
                  <surname>Kostrzewa-Szymiec</surname>
                  <given-names>D</given-names>
                </name>
                <name name-style="western">
                  <surname>Walkowiak</surname>
                  <given-names>J</given-names>
                </name>
                <name name-style="western">
                  <surname>Cichy</surname>
                  <given-names>W</given-names>
                </name>
              </person-group>
              <article-title>Congenital fructose intolerance diagnosed in a 13-year-old boy.</article-title>
              <source>Wiad Lek.</source>
              <year>1994</year>
              <volume>47</volume>
              <fpage>702</fpage>
              <lpage>4</lpage>
              <pub-id pub-id-type="pmid">7571625</pub-id>
            </element-citation>
          </ref>
          <ref id="hfi.REF.lazarin.2013.178">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Lazarin</surname>
                  <given-names>GA</given-names>
                </name>
                <name name-style="western">
                  <surname>Haque</surname>
                  <given-names>IS</given-names>
                </name>
                <name name-style="western">
                  <surname>Nazareth</surname>
                  <given-names>S</given-names>
                </name>
                <name name-style="western">
                  <surname>Iori</surname>
                  <given-names>K</given-names>
                </name>
                <name name-style="western">
                  <surname>Patterson</surname>
                  <given-names>AS</given-names>
                </name>
                <name name-style="western">
                  <surname>Jacobson</surname>
                  <given-names>JL</given-names>
                </name>
                <name name-style="western">
                  <surname>Marshall</surname>
                  <given-names>JR</given-names>
                </name>
                <name name-style="western">
                  <surname>Seltzer</surname>
                  <given-names>WK</given-names>
                </name>
                <name name-style="western">
                  <surname>Patrizio</surname>
                  <given-names>P</given-names>
                </name>
                <name name-style="western">
                  <surname>Evans</surname>
                  <given-names>EA</given-names>
                </name>
                <name name-style="western">
                  <surname>Srinivasan</surname>
                  <given-names>BS</given-names>
                </name>
              </person-group>
              <article-title>An empirical estimate of carrier frequencies for 400+ causal Mendelian variants: results from an ethnically diverse clinical sample of 23,453 individuals.</article-title>
              <source>Genet Med.</source>
              <year>2013</year>
              <volume>15</volume>
              <fpage>178</fpage>
              <lpage>86</lpage>
              <pub-id pub-id-type="pmid">22975760</pub-id>
            </element-citation>
          </ref>
          <ref id="hfi.REF.leonardi.1986.189">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Leonardi</surname>
                  <given-names>S</given-names>
                </name>
                <name name-style="western">
                  <surname>Fischer</surname>
                  <given-names>A</given-names>
                </name>
                <name name-style="western">
                  <surname>Di Dio</surname>
                  <given-names>R</given-names>
                </name>
                <name name-style="western">
                  <surname>D'Agata</surname>
                  <given-names>A</given-names>
                </name>
                <name name-style="western">
                  <surname>Musumeci</surname>
                  <given-names>S.</given-names>
                </name>
              </person-group>
              <article-title>Neonatal cholestasis: clinical and diagnostic setting.</article-title>
              <source>Pediatr Med Chir.</source>
              <year>1986</year>
              <volume>8</volume>
              <fpage>189</fpage>
              <lpage>200</lpage>
              <pub-id pub-id-type="pmid">3786181</pub-id>
            </element-citation>
          </ref>
          <ref id="hfi.REF.levin.1963.220">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Levin</surname>
                  <given-names>B</given-names>
                </name>
                <name name-style="western">
                  <surname>Oberholzer</surname>
                  <given-names>VG</given-names>
                </name>
                <name name-style="western">
                  <surname>Snodgrass</surname>
                  <given-names>GJ</given-names>
                </name>
                <name name-style="western">
                  <surname>Stimmler</surname>
                  <given-names>L</given-names>
                </name>
                <name name-style="western">
                  <surname>Wilmers</surname>
                  <given-names>MJ</given-names>
                </name>
              </person-group>
              <article-title>Fructosaemia: an inborn error of fructose metabolism.</article-title>
              <source>Arch Dis Child.</source>
              <year>1963</year>
              <volume>38</volume>
              <fpage>220</fpage>
              <lpage>30</lpage>
              <pub-id pub-id-type="pmid">13930101</pub-id>
            </element-citation>
          </ref>
          <ref id="hfi.REF.locher.1987.194">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Locher</surname>
                  <given-names>S.</given-names>
                </name>
              </person-group>
              <article-title>Acute liver and kidney failure following sorbitol infusion in a 28-year-old patient with undiagnosed fructose intolerance.</article-title>
              <source>Anasth Intensivther Notfallmed.</source>
              <year>1987</year>
              <volume>22</volume>
              <fpage>194</fpage>
              <lpage>7</lpage>
              <pub-id pub-id-type="pmid">3116878</pub-id>
            </element-citation>
          </ref>
          <ref id="hfi.REF.lu.2001.30407">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Lu</surname>
                  <given-names>M</given-names>
                </name>
                <name name-style="western">
                  <surname>Holliday</surname>
                  <given-names>LS</given-names>
                </name>
                <name name-style="western">
                  <surname>Zhang</surname>
                  <given-names>L</given-names>
                </name>
                <name name-style="western">
                  <surname>Dunn</surname>
                  <given-names>WA</given-names>
                  <suffix>Jr</suffix>
                </name>
                <name name-style="western">
                  <surname>Gluck</surname>
                  <given-names>SL</given-names>
                </name>
              </person-group>
              <article-title>Interaction between aldolase and vacuolar H+-ATPase: evidence for direct coupling of glycolysis to the ATP-hydrolyzing proton pump.</article-title>
              <source>J Biol Chem.</source>
              <year>2001</year>
              <volume>276</volume>
              <fpage>30407</fpage>
              <lpage>13</lpage>
              <pub-id pub-id-type="pmid">11399750</pub-id>
            </element-citation>
          </ref>
          <ref id="hfi.REF.maggiore.1982.169">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Maggiore</surname>
                  <given-names>G</given-names>
                </name>
                <name name-style="western">
                  <surname>Borgna-Pignatti</surname>
                  <given-names>C</given-names>
                </name>
              </person-group>
              <article-title>Disseminated intravascular coagulation associated with hereditary fructose intolerance.</article-title>
              <source>Am J Dis Child.</source>
              <year>1982</year>
              <volume>136</volume>
              <fpage>169</fpage>
              <lpage>70</lpage>
              <pub-id pub-id-type="pmid">7064932</pub-id>
            </element-citation>
          </ref>
          <ref id="hfi.REF.malay.2005.135">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Malay</surname>
                  <given-names>AD</given-names>
                </name>
                <name name-style="western">
                  <surname>Allen</surname>
                  <given-names>KN</given-names>
                </name>
                <name name-style="western">
                  <surname>Tolan</surname>
                  <given-names>DR</given-names>
                </name>
              </person-group>
              <article-title>Structure of the thermolabile mutant aldolase B, A149P: molecular basis of hereditary fructose intolerance.</article-title>
              <source>J Mol Biol.</source>
              <year>2005</year>
              <volume>347</volume>
              <fpage>135</fpage>
              <lpage>44</lpage>
              <pub-id pub-id-type="pmid">15733923</pub-id>
            </element-citation>
          </ref>
          <ref id="hfi.REF.mandel.1990.267">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Mandel</surname>
                  <given-names>H</given-names>
                </name>
                <name name-style="western">
                  <surname>Gozal</surname>
                  <given-names>D</given-names>
                </name>
                <name name-style="western">
                  <surname>Aizin</surname>
                  <given-names>A</given-names>
                </name>
                <name name-style="western">
                  <surname>Tavori</surname>
                  <given-names>S</given-names>
                </name>
                <name name-style="western">
                  <surname>Jaffe</surname>
                  <given-names>M</given-names>
                </name>
              </person-group>
              <article-title>Haemophagocytosis in hereditary fructose intolerance: a diagnostic dilemma.</article-title>
              <source>J Inherit Metab Dis.</source>
              <year>1990</year>
              <volume>13</volume>
              <fpage>267</fpage>
              <lpage>9</lpage>
              <pub-id pub-id-type="pmid">2122082</pub-id>
            </element-citation>
          </ref>
          <ref id="hfi.REF.marks.1989.362">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Marks</surname>
                  <given-names>F</given-names>
                </name>
                <name name-style="western">
                  <surname>Ordorica</surname>
                  <given-names>S</given-names>
                </name>
                <name name-style="western">
                  <surname>Hoskins</surname>
                  <given-names>I</given-names>
                </name>
                <name name-style="western">
                  <surname>Young</surname>
                  <given-names>BK</given-names>
                </name>
              </person-group>
              <article-title>Congenital hereditary fructose intolerance and pregnancy.</article-title>
              <source>Am J Obstet Gynecol</source>
              <year>1989</year>
              <volume>160</volume>
              <fpage>362</fpage>
              <lpage>3</lpage>
              <pub-id pub-id-type="pmid">2916618</pub-id>
            </element-citation>
          </ref>
          <ref id="hfi.REF.marthaler.1967.597">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Marthaler</surname>
                  <given-names>TM</given-names>
                </name>
                <name name-style="western">
                  <surname>Froesch</surname>
                  <given-names>ER</given-names>
                </name>
              </person-group>
              <article-title>Hereditary fructose intolerance. Dental status of eight patients.</article-title>
              <source>Br Dent J.</source>
              <year>1967</year>
              <volume>123</volume>
              <fpage>597</fpage>
              <lpage>9</lpage>
              <pub-id pub-id-type="pmid">5234813</pub-id>
            </element-citation>
          </ref>
          <ref id="hfi.REF.mass.1966.516">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Mass</surname>
                  <given-names>RE</given-names>
                </name>
                <name name-style="western">
                  <surname>Smith</surname>
                  <given-names>WR</given-names>
                </name>
                <name name-style="western">
                  <surname>Walsh</surname>
                  <given-names>JR</given-names>
                </name>
              </person-group>
              <article-title>The association of hereditary fructose intolerance and renal tubular acidosis.</article-title>
              <source>Am J Med Sci.</source>
              <year>1966</year>
              <volume>251</volume>
              <fpage>516</fpage>
              <lpage>23</lpage>
              <pub-id pub-id-type="pmid">5933765</pub-id>
            </element-citation>
          </ref>
          <ref id="hfi.REF.michelakakis.2009.81">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Michelakakis</surname>
                  <given-names>H</given-names>
                </name>
                <name name-style="western">
                  <surname>Moraitou</surname>
                  <given-names>M</given-names>
                </name>
                <name name-style="western">
                  <surname>Mavridou</surname>
                  <given-names>I</given-names>
                </name>
                <name name-style="western">
                  <surname>Dimitriou</surname>
                  <given-names>E</given-names>
                </name>
              </person-group>
              <article-title>Plasma lysosomal enzyme activities in congenital disorders of glycosylation, galactosemia and fructosemia.</article-title>
              <source>Clin Chim Acta.</source>
              <year>2009</year>
              <volume>401</volume>
              <fpage>81</fpage>
              <lpage>3</lpage>
              <pub-id pub-id-type="pmid">19100247</pub-id>
            </element-citation>
          </ref>
          <ref id="hfi.REF.mock.1983.764">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Mock</surname>
                  <given-names>DM</given-names>
                </name>
                <name name-style="western">
                  <surname>Perman</surname>
                  <given-names>JA</given-names>
                </name>
                <name name-style="western">
                  <surname>Thaler</surname>
                  <given-names>M</given-names>
                </name>
                <name name-style="western">
                  <surname>Morris</surname>
                  <given-names>RC</given-names>
                  <suffix>Jr</suffix>
                </name>
              </person-group>
              <article-title>Chronic fructose intoxication after infancy in children with hereditary fructose intolerance. A cause of growth retardation.</article-title>
              <source>N Engl J Med.</source>
              <year>1983</year>
              <volume>309</volume>
              <fpage>764</fpage>
              <lpage>70</lpage>
              <pub-id pub-id-type="pmid">6888454</pub-id>
            </element-citation>
          </ref>
          <ref id="hfi.REF.morris.1968.1648">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Morris</surname>
                  <given-names>RC</given-names>
                  <suffix>Jr</suffix>
                </name>
              </person-group>
              <article-title>An experimental renal acidification defect in patients with hereditary fructose intolerance.</article-title>
              <source>J Clin Invest.</source>
              <year>1968</year>
              <volume>47</volume>
              <fpage>1648</fpage>
              <lpage>63</lpage>
              <pub-id pub-id-type="pmid">5658593</pub-id>
            </element-citation>
          </ref>
          <ref id="hfi.REF.m_ller.2003.276">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>M&#x000fc;ller</surname>
                  <given-names>P</given-names>
                </name>
                <name name-style="western">
                  <surname>Meier</surname>
                  <given-names>C</given-names>
                </name>
                <name name-style="western">
                  <surname>B&#x000f6;hme</surname>
                  <given-names>HJ</given-names>
                </name>
                <name name-style="western">
                  <surname>Richter</surname>
                  <given-names>T</given-names>
                </name>
              </person-group>
              <article-title>Fructose breath hydrogen test--is it really a harmless diagnostic procedure?</article-title>
              <source>Dig Dis.</source>
              <year>2003</year>
              <volume>21</volume>
              <fpage>276</fpage>
              <lpage>8</lpage>
              <pub-id pub-id-type="pmid">14571104</pub-id>
            </element-citation>
          </ref>
          <ref id="hfi.REF.newbrun.1980.619">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Newbrun</surname>
                  <given-names>E</given-names>
                </name>
                <name name-style="western">
                  <surname>Hoover</surname>
                  <given-names>C</given-names>
                </name>
                <name name-style="western">
                  <surname>Mettraux</surname>
                  <given-names>G</given-names>
                </name>
                <name name-style="western">
                  <surname>Graf</surname>
                  <given-names>H</given-names>
                </name>
              </person-group>
              <article-title>Comparison of dietary habits and dental health of subjects with hereditary fructose intolerance and control subjects.</article-title>
              <source>J Am Dent Assoc.</source>
              <year>1980</year>
              <volume>101</volume>
              <fpage>619</fpage>
              <lpage>26</lpage>
              <pub-id pub-id-type="pmid">6934214</pub-id>
            </element-citation>
          </ref>
          <ref id="hfi.REF.oberhaensli.1987.931">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Oberhaensli</surname>
                  <given-names>RD</given-names>
                </name>
                <name name-style="western">
                  <surname>Rajagopalan</surname>
                  <given-names>B</given-names>
                </name>
                <name name-style="western">
                  <surname>Taylor</surname>
                  <given-names>DJ</given-names>
                </name>
                <name name-style="western">
                  <surname>Radda</surname>
                  <given-names>GK</given-names>
                </name>
                <name name-style="western">
                  <surname>Collins</surname>
                  <given-names>JE</given-names>
                </name>
                <name name-style="western">
                  <surname>Leonard</surname>
                  <given-names>JV</given-names>
                </name>
                <name name-style="western">
                  <surname>Schwarz</surname>
                  <given-names>H</given-names>
                </name>
                <name name-style="western">
                  <surname>Herschkowitz</surname>
                  <given-names>N</given-names>
                </name>
              </person-group>
              <article-title>Study of hereditary fructose intolerance by use of 31P magnetic resonance spectroscopy.</article-title>
              <source>Lancet.</source>
              <year>1987</year>
              <volume>2</volume>
              <fpage>931</fpage>
              <lpage>4</lpage>
              <pub-id pub-id-type="pmid">2889861</pub-id>
            </element-citation>
          </ref>
          <ref id="hfi.REF.odi_vre.1978.605">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Odi&#x000e8;vre</surname>
                  <given-names>M</given-names>
                </name>
                <name name-style="western">
                  <surname>Gentil</surname>
                  <given-names>C</given-names>
                </name>
                <name name-style="western">
                  <surname>Gautier</surname>
                  <given-names>M</given-names>
                </name>
                <name name-style="western">
                  <surname>Alagille</surname>
                  <given-names>D</given-names>
                </name>
              </person-group>
              <article-title>Hereditary fructose intolerance in childhood. Diagnosis, management, and course in 55 patients.</article-title>
              <source>Am J Dis Child</source>
              <year>1978</year>
              <volume>132</volume>
              <fpage>605</fpage>
              <lpage>8</lpage>
              <pub-id pub-id-type="pmid">655145</pub-id>
            </element-citation>
          </ref>
          <ref id="hfi.REF.paolella.2012.64">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Paolella</surname>
                  <given-names>G</given-names>
                </name>
                <name name-style="western">
                  <surname>Pisano</surname>
                  <given-names>P</given-names>
                </name>
                <name name-style="western">
                  <surname>Albano</surname>
                  <given-names>R</given-names>
                </name>
                <name name-style="western">
                  <surname>Cannaviello</surname>
                  <given-names>L</given-names>
                </name>
                <name name-style="western">
                  <surname>Mauro</surname>
                  <given-names>C</given-names>
                </name>
                <name name-style="western">
                  <surname>Esposito</surname>
                  <given-names>G</given-names>
                </name>
                <name name-style="western">
                  <surname>Vajro</surname>
                  <given-names>P</given-names>
                </name>
              </person-group>
              <article-title>Fatty liver disease and hypertransaminasemia hiding the association of clinically silent Duchenne muscular dystrophy and hereditary fructose intolerance.</article-title>
              <source>Ital J Pediatr.</source>
              <year>2012</year>
              <volume>38</volume>
              <fpage>64</fpage>
              <pub-id pub-id-type="pmid">23114028</pub-id>
            </element-citation>
          </ref>
          <ref id="hfi.REF.pronicka.2007.101">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Pronicka</surname>
                  <given-names>E</given-names>
                </name>
                <name name-style="western">
                  <surname>Adamowicz</surname>
                  <given-names>M</given-names>
                </name>
                <name name-style="western">
                  <surname>Kowalik</surname>
                  <given-names>A</given-names>
                </name>
                <name name-style="western">
                  <surname>P&#x00142;oski</surname>
                  <given-names>R</given-names>
                </name>
                <name name-style="western">
                  <surname>Radomyska</surname>
                  <given-names>B</given-names>
                </name>
                <name name-style="western">
                  <surname>Rogaszewska</surname>
                  <given-names>M</given-names>
                </name>
                <name name-style="western">
                  <surname>Rokicki</surname>
                  <given-names>D</given-names>
                </name>
                <name name-style="western">
                  <surname>Sykut-Cegielska</surname>
                  <given-names>J.</given-names>
                </name>
              </person-group>
              <article-title>Elevated carbohydrate-deficient transferrin (CDT) and its normalization on dietary treatment as a useful biochemical test for hereditary fructose intolerance and galactosemia.</article-title>
              <source>Pediatr Res.</source>
              <year>2007</year>
              <volume>62</volume>
              <fpage>101</fpage>
              <lpage>5</lpage>
              <pub-id pub-id-type="pmid">17515832</pub-id>
            </element-citation>
          </ref>
          <ref id="hfi.REF.quintana.2009.s273">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Quintana</surname>
                  <given-names>E</given-names>
                </name>
                <name name-style="western">
                  <surname>Sturiale</surname>
                  <given-names>L</given-names>
                </name>
                <name name-style="western">
                  <surname>Montero</surname>
                  <given-names>R</given-names>
                </name>
                <name name-style="western">
                  <surname>Andrade</surname>
                  <given-names>F</given-names>
                </name>
                <name name-style="western">
                  <surname>Fernandez</surname>
                  <given-names>C</given-names>
                </name>
                <name name-style="western">
                  <surname>Couce</surname>
                  <given-names>ML</given-names>
                </name>
                <name name-style="western">
                  <surname>Barone</surname>
                  <given-names>R</given-names>
                </name>
                <name name-style="western">
                  <surname>Aldamiz-Echevarria</surname>
                  <given-names>L</given-names>
                </name>
                <name name-style="western">
                  <surname>Ribes</surname>
                  <given-names>A</given-names>
                </name>
                <name name-style="western">
                  <surname>Artuch</surname>
                  <given-names>R</given-names>
                </name>
                <name name-style="western">
                  <surname>Briones</surname>
                  <given-names>P</given-names>
                </name>
              </person-group>
              <article-title>Secondary disorders of glycosylation in inborn errors of fructose metabolism.</article-title>
              <source>J Inherit Metab Dis.</source>
              <year>2009</year>
              <volume>32</volume>
              <supplement>Suppl 1</supplement>
              <fpage>S273</fpage>
              <lpage>8</lpage>
              <pub-id pub-id-type="pmid">19768653</pub-id>
            </element-citation>
          </ref>
          <ref id="hfi.REF.sachs.1993.56">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Sachs</surname>
                  <given-names>M</given-names>
                </name>
                <name name-style="western">
                  <surname>Asskali</surname>
                  <given-names>F</given-names>
                </name>
                <name name-style="western">
                  <surname>F&#x000f6;rster</surname>
                  <given-names>H</given-names>
                </name>
                <name name-style="western">
                  <surname>Encke</surname>
                  <given-names>A</given-names>
                </name>
              </person-group>
              <article-title>Repeated perioperative administration of fructose and sorbitol in a female patient with hereditary fructose intolerance.</article-title>
              <source>Z Ernahrungswiss</source>
              <year>1993</year>
              <volume>32</volume>
              <fpage>56</fpage>
              <lpage>66</lpage>
              <pub-id pub-id-type="pmid">8484270</pub-id>
            </element-citation>
          </ref>
          <ref id="hfi.REF.s_nchezguti_rrez.2002.e56">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>S&#x000e1;nchez-Guti&#x000e9;rrez</surname>
                  <given-names>JC</given-names>
                </name>
                <name name-style="western">
                  <surname>Benlloch</surname>
                  <given-names>T</given-names>
                </name>
                <name name-style="western">
                  <surname>Leal</surname>
                  <given-names>MA</given-names>
                </name>
                <name name-style="western">
                  <surname>Samper</surname>
                  <given-names>B</given-names>
                </name>
                <name name-style="western">
                  <surname>Garc&#x000ed;a-Ripoll</surname>
                  <given-names>I</given-names>
                </name>
                <name name-style="western">
                  <surname>Fel&#x000ed;u</surname>
                  <given-names>JE</given-names>
                </name>
              </person-group>
              <article-title>Molecular analysis of the aldolase B gene in patients with hereditary fructose intolerance from Spain.</article-title>
              <source>J Med Genet.</source>
              <year>2002</year>
              <volume>39</volume>
              <fpage>e56</fpage>
              <pub-id pub-id-type="pmid">12205126</pub-id>
            </element-citation>
          </ref>
          <ref id="hfi.REF.santer.2005.594">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Santer</surname>
                  <given-names>R</given-names>
                </name>
                <name name-style="western">
                  <surname>Rischewski</surname>
                  <given-names>J</given-names>
                </name>
                <name name-style="western">
                  <surname>von Weihe</surname>
                  <given-names>M</given-names>
                </name>
                <name name-style="western">
                  <surname>Niederhaus</surname>
                  <given-names>M</given-names>
                </name>
                <name name-style="western">
                  <surname>Schneppenheim</surname>
                  <given-names>S</given-names>
                </name>
                <name name-style="western">
                  <surname>Baerlocher</surname>
                  <given-names>K</given-names>
                </name>
                <name name-style="western">
                  <surname>Kohlsch&#x000fc;tter</surname>
                  <given-names>A</given-names>
                </name>
                <name name-style="western">
                  <surname>Muntau</surname>
                  <given-names>A</given-names>
                </name>
                <name name-style="western">
                  <surname>Posselt</surname>
                  <given-names>HG</given-names>
                </name>
                <name name-style="western">
                  <surname>Steinmann</surname>
                  <given-names>B</given-names>
                </name>
                <name name-style="western">
                  <surname>Schneppenheim</surname>
                  <given-names>R</given-names>
                </name>
              </person-group>
              <article-title>The spectrum of aldolase B (ALDOB) mutations and the prevalence of hereditary fructose intolerance in Central Europe.</article-title>
              <source>Hum Mutat</source>
              <year>2005</year>
              <volume>25</volume>
              <fpage>594</fpage>
              <pub-id pub-id-type="pmid">15880727</pub-id>
            </element-citation>
          </ref>
          <ref id="hfi.REF.sax_n.1989.150">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Sax&#x000e9;n</surname>
                  <given-names>L</given-names>
                </name>
                <name name-style="western">
                  <surname>Jousimies-Somer</surname>
                  <given-names>H</given-names>
                </name>
                <name name-style="western">
                  <surname>Kaisla</surname>
                  <given-names>A</given-names>
                </name>
                <name name-style="western">
                  <surname>Kanervo</surname>
                  <given-names>A</given-names>
                </name>
                <name name-style="western">
                  <surname>Summanen</surname>
                  <given-names>P</given-names>
                </name>
                <name name-style="western">
                  <surname>Sipil&#x000e4;</surname>
                  <given-names>I</given-names>
                </name>
              </person-group>
              <article-title>Subgingival microflora, dental and periodontal conditions in patients with hereditary fructose intolerance.</article-title>
              <source>Scand J Dent Res.</source>
              <year>1989</year>
              <volume>97</volume>
              <fpage>150</fpage>
              <lpage>8</lpage>
              <pub-id pub-id-type="pmid">2704977</pub-id>
            </element-citation>
          </ref>
          <ref id="hfi.REF.schrodi.2015.659">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Schrodi</surname>
                  <given-names>SJ</given-names>
                </name>
                <name name-style="western">
                  <surname>DeBarber</surname>
                  <given-names>A</given-names>
                </name>
                <name name-style="western">
                  <surname>He</surname>
                  <given-names>M</given-names>
                </name>
                <name name-style="western">
                  <surname>Ye</surname>
                  <given-names>Z</given-names>
                </name>
                <name name-style="western">
                  <surname>Peissig</surname>
                  <given-names>P</given-names>
                </name>
                <name name-style="western">
                  <surname>Van Wormer</surname>
                  <given-names>JJ</given-names>
                </name>
                <name name-style="western">
                  <surname>Haws</surname>
                  <given-names>R</given-names>
                </name>
                <name name-style="western">
                  <surname>Brilliant</surname>
                  <given-names>MH</given-names>
                </name>
                <name name-style="western">
                  <surname>Steiner</surname>
                  <given-names>RD</given-names>
                </name>
              </person-group>
              <article-title>Prevalence estimation for monogenic autosomal recessive diseases using population-based genetic data.</article-title>
              <source>Hum Genet.</source>
              <year>2015</year>
              <volume>134</volume>
              <fpage>659</fpage>
              <lpage>69</lpage>
              <pub-id pub-id-type="pmid">25893794</pub-id>
            </element-citation>
          </ref>
          <ref id="hfi.REF.seegmiller.1990.8326">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Seegmiller</surname>
                  <given-names>JE</given-names>
                </name>
                <name name-style="western">
                  <surname>Dixon</surname>
                  <given-names>RM</given-names>
                </name>
                <name name-style="western">
                  <surname>Kemp</surname>
                  <given-names>GJ</given-names>
                </name>
                <name name-style="western">
                  <surname>Angus</surname>
                  <given-names>PW</given-names>
                </name>
                <name name-style="western">
                  <surname>McAlindon</surname>
                  <given-names>TE</given-names>
                </name>
                <name name-style="western">
                  <surname>Dieppe</surname>
                  <given-names>P</given-names>
                </name>
                <name name-style="western">
                  <surname>Rajagopalan</surname>
                  <given-names>B</given-names>
                </name>
                <name name-style="western">
                  <surname>Radda</surname>
                  <given-names>GK</given-names>
                </name>
              </person-group>
              <article-title>Fructose-induced aberration of metabolism in familial gout identified by 31P magnetic resonance spectroscopy.</article-title>
              <source>Proc Natl Acad Sci U S A.</source>
              <year>1990</year>
              <volume>87</volume>
              <fpage>8326</fpage>
              <lpage>30</lpage>
              <pub-id pub-id-type="pmid">2236043</pub-id>
            </element-citation>
          </ref>
          <ref id="hfi.REF.steinmann.2011">
            <mixed-citation publication-type="book">Steinmann B, Santer R. Disorders of fructose metabolism. In: Saudubray JM, van den Berghe G, Walter J, eds. <italic toggle="yes">Inherited Metabolic Diseases</italic>. 5 ed. Berlin, Germany: Springer. 2011:159-62.</mixed-citation>
          </ref>
          <ref id="hfi.REF.thabet.2002.581">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Thabet</surname>
                  <given-names>F</given-names>
                </name>
                <name name-style="western">
                  <surname>Durand</surname>
                  <given-names>P</given-names>
                </name>
                <name name-style="western">
                  <surname>Chevret</surname>
                  <given-names>L</given-names>
                </name>
                <name name-style="western">
                  <surname>Fabre</surname>
                  <given-names>M</given-names>
                </name>
                <name name-style="western">
                  <surname>Debray</surname>
                  <given-names>D</given-names>
                </name>
                <name name-style="western">
                  <surname>Brivet</surname>
                  <given-names>M</given-names>
                </name>
                <name name-style="western">
                  <surname>Devictor</surname>
                  <given-names>D.</given-names>
                </name>
              </person-group>
              <article-title>Severe Reye syndrome: report of 14 cases managed in a pediatric intensive care unit over 11 years.</article-title>
              <source>Arch Pediatr.</source>
              <year>2002</year>
              <volume>9</volume>
              <fpage>581</fpage>
              <lpage>6</lpage>
              <pub-id pub-id-type="pmid">12108311</pub-id>
            </element-citation>
          </ref>
          <ref id="hfi.REF.van_den_berghe.1973.637">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Van Den Berghe</surname>
                  <given-names>G</given-names>
                </name>
                <name name-style="western">
                  <surname>Hue</surname>
                  <given-names>L</given-names>
                </name>
                <name name-style="western">
                  <surname>Hers</surname>
                  <given-names>HG</given-names>
                </name>
              </person-group>
              <article-title>Effect of administration of the fructose on the glycogenolytic action of glucagon. An investigation of the pathogeny of hereditary fructose intolerance.</article-title>
              <source>Biochem J.</source>
              <year>1973</year>
              <volume>134</volume>
              <fpage>637</fpage>
              <lpage>45</lpage>
              <pub-id pub-id-type="pmid">16742826</pub-id>
            </element-citation>
          </ref>
          <ref id="hfi.REF.w_ssmann.2000.108">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>W&#x000f6;ssmann</surname>
                  <given-names>W</given-names>
                </name>
                <name name-style="western">
                  <surname>Wiemann</surname>
                  <given-names>J</given-names>
                </name>
                <name name-style="western">
                  <surname>K&#x000f6;rber</surname>
                  <given-names>F</given-names>
                </name>
                <name name-style="western">
                  <surname>Gortner</surname>
                  <given-names>L.</given-names>
                </name>
              </person-group>
              <article-title>Hereditary fructose intolerance (HFI) as cause of isolated gamma GT rise in a 5-year old boy with hepatomegaly.</article-title>
              <source>Klin Padiatr.</source>
              <year>2000</year>
              <volume>212</volume>
              <fpage>108</fpage>
              <lpage>9</lpage>
              <pub-id pub-id-type="pmid">10916780</pub-id>
            </element-citation>
          </ref>
          <ref id="hfi.REF.yang.2000.218">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Yang</surname>
                  <given-names>TY</given-names>
                </name>
                <name name-style="western">
                  <surname>Chen</surname>
                  <given-names>HL</given-names>
                </name>
                <name name-style="western">
                  <surname>Ni</surname>
                  <given-names>YH</given-names>
                </name>
                <name name-style="western">
                  <surname>Hwu</surname>
                  <given-names>WL</given-names>
                </name>
                <name name-style="western">
                  <surname>Chang</surname>
                  <given-names>MH</given-names>
                </name>
              </person-group>
              <article-title>Hereditary fructose intolerance presenting as Reye's-like syndrome: report of one case</article-title>
              <source>Acta Paediatr Taiwan.</source>
              <year>2000</year>
              <volume>41</volume>
              <fpage>218</fpage>
              <lpage>20</lpage>
              <pub-id pub-id-type="pmid">11021009</pub-id>
            </element-citation>
          </ref>
        </ref-list>
      </sec>
      <sec id="hfi.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="hfi.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>17 December 2015 (me) Review posted live</p>
            </list-item>
            <list-item>
              <p>15 July 2015 (jwa) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
